var data={"title":"Oral lesions","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Oral lesions</div><dl id=\"topicContributors\"><dt><span> </span>Authors:</dt><dd><a href=\"https://www.uptodate.com/contents/oral-lesions/contributors\" class=\"contributor contributor_credentials\">Beth G Goldstein, MD</a></dd><dd><a href=\"https://www.uptodate.com/contents/oral-lesions/contributors\" class=\"contributor contributor_credentials\">Adam O Goldstein, MD, MPH</a></dd><dt><span> </span>Section Editors:</dt><dd><a href=\"https://www.uptodate.com/contents/oral-lesions/contributors\" class=\"contributor contributor_credentials\">Robert P Dellavalle, MD, PhD, MSPH</a></dd><dd><a href=\"https://www.uptodate.com/contents/oral-lesions/contributors\" class=\"contributor contributor_credentials\">Daniel G Deschler, MD, FACS</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/oral-lesions/contributors\" class=\"contributor contributor_credentials\">Rosamaria Corona, MD, DSc</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/oral-lesions/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Sep 20, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Diagnosing and treating dermatologic lesions of the mouth and gums is challenging for most clinicians because of the wide variety of disease processes that can present with similar appearing lesions and the fact that most clinicians receive inadequate training in mouth diseases. In a study of oral lesions in older adult patients, for example, almost all clinicians surveyed felt that it was important to examine older patients' mouths, but less than one-fifth stated that they routinely performed such examinations [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/1\" class=\"abstract_t\">1</a>]. Almost four-fifths did not correctly diagnose a clinical picture of an early squamous cell carcinoma.</p><p>One of the keys to improving accuracy in diagnosing oral lesions is forming an appropriate differential diagnosis. This review will discuss the presentation and treatment of the most common oral lesions, including tumors, infections, autoimmune and connective tissues diseases, aphthous ulcers, and other miscellaneous oral lesions.</p><p>Gingivitis, periodontal disease, odontogenic infections, and halitosis are discussed separately. (See <a href=\"topic.htm?path=gingivitis-and-periodontitis-in-adults-classification-and-dental-treatment\" class=\"medical medical_review\">&quot;Gingivitis and periodontitis in adults: Classification and dental treatment&quot;</a> and <a href=\"topic.htm?path=epidemiology-pathogenesis-and-clinical-manifestations-of-odontogenic-infections\" class=\"medical medical_review\">&quot;Epidemiology, pathogenesis, and clinical manifestations of odontogenic infections&quot;</a> and <a href=\"topic.htm?path=bad-breath\" class=\"medical medical_review\">&quot;Bad breath&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">TUMORS (AND LESIONS THAT MIMIC)</span></p><p class=\"headingAnchor\" id=\"H3\"><span class=\"h2\">Squamous cell carcinoma</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Cancer of the oral cavity is associated with ulcers or masses that do not heal and with dental changes or poorly fitting dentures. Tongue and lip cancers present as exophytic or ulcerative lesions often associated with pain. Up to two-thirds of patients with primary tongue lesions have nodal disease; the incidence is substantially lower in patients with hard palate and lip cancers. (See <a href=\"topic.htm?path=overview-of-treatment-for-head-and-neck-cancer\" class=\"medical medical_review\">&quot;Overview of treatment for head and neck cancer&quot;</a> and <a href=\"topic.htm?path=overview-of-the-diagnosis-and-staging-of-head-and-neck-cancer\" class=\"medical medical_review\">&quot;Overview of the diagnosis and staging of head and neck cancer&quot;</a>.)</p><p>Persistent papules, plaques, erosions, or ulcers in the mouth should be biopsied to rule out squamous cell carcinoma, particularly in patients with appropriate risk factors (<a href=\"image.htm?imageKey=DERM%2F81810%7EDERM%2F59057%7EDERM%2F74239\" class=\"graphic graphic_picture graphicRef81810 graphicRef59057 graphicRef74239 \">picture 1A-C</a>). It has been estimated that the use of tobacco and alcohol account for up to 80 percent of cases of squamous cell carcinoma of the head and neck [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/1\" class=\"abstract_t\">1</a>]. The combined effect of alcohol and smoking is multiplicative with the risk of developing head and neck cancer being as much as 200 times greater for heavy smokers and drinkers. A subset of oropharyngeal squamous cell carcinoma is associated with human papillomavirus (HPV) infection, particularly with high-risk type 16 (HPV-16). Oral infection with HPV-16 confers an approximately 50-fold increase in risk for HPV-positive oropharyngeal squamous cell carcinoma [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/2\" class=\"abstract_t\">2</a>]. (See <a href=\"topic.htm?path=epidemiology-and-risk-factors-for-head-and-neck-cancer\" class=\"medical medical_review\">&quot;Epidemiology and risk factors for head and neck cancer&quot;</a> and <a href=\"topic.htm?path=human-papillomavirus-associated-head-and-neck-cancer\" class=\"medical medical_review\">&quot;Human papillomavirus associated head and neck cancer&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H4\"><span class=\"h2\">Leukoplakia</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Oral leukoplakia is a precancerous lesion that presents as white patches or plaques of the oral mucosa (<a href=\"image.htm?imageKey=DERM%2F81049%7EDERM%2F60939%7EDERM%2F72711\" class=\"graphic graphic_picture graphicRef81049 graphicRef60939 graphicRef72711 \">picture 2A-C</a>). It represents hyperplasia of the squamous epithelium, which is believed to be an early step in the transformation of clonally independent premalignant lesions from hyperplasia, to dysplasia, to carcinoma in situ, to invasive malignant lesions (see <a href=\"topic.htm?path=head-and-neck-squamous-cell-carcinogenesis-molecular-and-genetic-alterations\" class=\"medical medical_review\">&quot;Head and neck squamous cell carcinogenesis: Molecular and genetic alterations&quot;</a>). Leukoplakia is also seen in purely inflammatory conditions not associated with malignancy. An association exists between leukoplakia and human papillomavirus (HPV) [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/3\" class=\"abstract_t\">3</a>].</p><p>Leukoplakia itself is a benign reactive process. However, between 1 and 20 percent of lesions will progress to carcinoma within 10 years. The clinical significance and natural history of oral leukoplakia depends upon the presence and degree of dysplasia [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/4-6\" class=\"abstract_t\">4-6</a>]. As an example, squamous hyperplasia is a common response to carcinogen exposure, mechanical irritation, or other noxious stimuli. Leukoplakic lesions that arise in trauma-prone regions of the oral cavity (cheek, dorsum of tongue), where the mucosal is normally thick, show evidence of dysplasia less often than do lesions in areas where the mucosal is normally thin (ventral tongue, retromolar triangle). In these last regions, carcinogen exposure is a proportionately greater cause than mechanical trauma.</p><p>Risk factors for oral leukoplakia are similar to that of squamous cell carcinoma; it is particularly common in smokeless tobacco users [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/7\" class=\"abstract_t\">7</a>]. Any indurated areas should be biopsied to rule out carcinomatous changes. In addition, developments in chemoprevention, most notably the demonstration of the impact of retinoid compounds on premalignant lesions of the oral cavity and oropharynx, have triggered renewed interest in possible preventive approaches to oropharyngeal cancer in patients with precancerous lesions. (See <a href=\"topic.htm?path=chemoprevention-and-screening-in-oral-dysplasia-and-squamous-cell-head-and-neck-cancer\" class=\"medical medical_review\">&quot;Chemoprevention and screening in oral dysplasia and squamous cell head and neck cancer&quot;</a>.)</p><p>A separate disorder that is not premalignant is oral hairy leukoplakia, an Epstein-Barr virus-induced lesion that occurs almost entirely in HIV-infected patients. (See <a href=\"topic.htm?path=clinical-manifestations-and-treatment-of-epstein-barr-virus-infection#H9\" class=\"medical medical_review\">&quot;Clinical manifestations and treatment of Epstein-Barr virus infection&quot;, section on 'Oral hairy leukoplakia'</a>.)</p><p class=\"headingAnchor\" id=\"H60611044\"><span class=\"h3\">Oral proliferative verrucous leukoplakia</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Oral proliferative verrucous leukoplakia (OPVL) is&nbsp;a rare, aggressive form of oral leukoplakia characterized by multifocality and a strong tendency to develop exophytic and wart-like lesions and to undergo malignant transformation [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/8-10\" class=\"abstract_t\">8-10</a>]. It occurs in all ethnic groups and appears to be more frequent in older women. The cause is unknown; in contrast with conventional leukoplakia, there is no clear association with tobacco or alcohol use, or HPV infection [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/10\" class=\"abstract_t\">10</a>]. Based upon data from a systematic review of 20 studies including over 300 patients,&nbsp;the rate of transformation into oral squamous cell carcinoma is approximately 60 percent over an average follow-up period of seven years. </p><p>OPVL presents initially as a single or multiple leukoplakic areas located on the gingiva, oral mucosa, or tongue. Over time, lesions tend become diffuse and develop exophytic, wart-like or erythroplakic areas, which may transform into squamous cell carcinoma (<a href=\"image.htm?imageKey=DERM%2F95480\" class=\"graphic graphic_picture graphicRef95480 \">picture 3</a>).</p><p>There are no specific clinical or histologic diagnostic criteria for OPVL. The diagnosis is based upon combined clinical and histopathologic evidence of progression. The diagnosis is particularly difficult in the early stages of disease, because lesions may mimic clinically and histologically conventional leukoplakia or oral lichen planus. </p><p>Clinical clues to the diagnosis of OPVL include: multifocal lesions; presence of verrucous areas; lesions recurring after treatment; female sex; and lack of exposure to tobacco [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/11\" class=\"abstract_t\">11</a>]. Early pathologic features that may suggest OPVL include: a dense lichenoid chronic inflammation (basal vacuolar degeneration, apoptotic cells, eosinophilic bodies, and a band-like lymphocytic infiltrate); wavy hyperorthokeratosis; and exophytic warty configuration (<a href=\"image.htm?imageKey=DERM%2F95484\" class=\"graphic graphic_picture graphicRef95484 \">picture 4</a>). </p><p>There is no curative treatment for OPVL. Multiple therapies have been tried for temporary control of the disease, including surgical excision, CO<sub>2</sub> and Nd:YAG laser ablation, cryotherapy, radiation therapy, photodynamic therapy, topical <a href=\"topic.htm?path=bleomycin-drug-information\" class=\"drug drug_general\">bleomycin</a>, and oral retinoids [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/12-14\" class=\"abstract_t\">12-14</a>]. Recurrence rates of up to 90 percent have been reported for all treatment modalities.</p><p>Patients with OPVL require lifelong close clinical and histopathologic monitoring for the development of squamous cell carcinoma. The mortality rate after an average follow-up time of 10 years is approximately 30 percent [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/10\" class=\"abstract_t\">10</a>]. </p><p class=\"headingAnchor\" id=\"H5\"><span class=\"h2\">Melanoma</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Melanoma should be included in the differential diagnosis of oral pigmented lesions that have any of the features of cutaneous melanoma, such as asymmetry, irregular borders, variable or changing color (ruling out the presence of an amalgam tattoo), or increasing diameter [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/15\" class=\"abstract_t\">15</a>] (see <a href=\"topic.htm?path=screening-and-early-detection-of-melanoma-in-adults-and-adolescents\" class=\"medical medical_review\">&quot;Screening and early detection of melanoma in adults and adolescents&quot;</a>). Melanoma of the oral cavity is frequently diagnosed at more advanced stages because of the failure of patients and providers to recognize it at an early stage [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/16\" class=\"abstract_t\">16</a>]. (See <a href=\"topic.htm?path=initial-surgical-management-of-melanoma-of-the-skin-and-unusual-sites\" class=\"medical medical_review\">&quot;Initial surgical management of melanoma of the skin and unusual sites&quot;</a>.)</p><p>These lesions must be differentiated from melanosis, which is extremely common in individuals with dark skin and generally appears in a symmetric pattern. Also in the differential are oral melanotic macules. These are darkly pigmented benign macules that occur on the lips and on the oral mucosa [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/17\" class=\"abstract_t\">17</a>]. These lesions are typically symmetric with sharp borders, present in adulthood, and are stable.</p><p>Surgery is the first choice of therapy for mucosal melanomas of the head and neck. Whenever possible the lesion should be resected with negative margins. Radiation therapy may be used to achieve local control if the lesion cannot be resected with negative margins. (See <a href=\"topic.htm?path=initial-surgical-management-of-melanoma-of-the-skin-and-unusual-sites\" class=\"medical medical_review\">&quot;Initial surgical management of melanoma of the skin and unusual sites&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H78046470\"><span class=\"h2\">Granular cell tumor</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The granular cell tumor is a benign neoplasm of neural origin composed of cells with granular cytoplasm. Most often, they present as solitary nodules affecting the dorsum of the tongue (<a href=\"image.htm?imageKey=DERM%2F100363\" class=\"graphic graphic_picture graphicRef100363 \">picture 5</a>), but may also occur in the skin, breasts, and internal organs [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/18\" class=\"abstract_t\">18</a>]. Histologically, granular cell tumors are characterized by sheets or cords of large polygonal cells with small, round, central nuclei and an eosinophilic, coarse, and granular cytoplasm (<a href=\"image.htm?imageKey=DERM%2F100364\" class=\"graphic graphic_picture graphicRef100364 \">picture 6</a>). Occasionally, larger eosinophilic granules surrounded by a clear halo called pustulo-ovoid bodies of Milian can be seen. Treatment is surgical excision.</p><p class=\"headingAnchor\" id=\"H6\"><span class=\"h2\">Amalgam tattoos</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Amalgam tattoos are blue-black macules seen in the adjacent gingival margin or proximal buccal mucosa near amalgam dental fillings (<a href=\"image.htm?imageKey=DERM%2F51720\" class=\"graphic graphic_picture graphicRef51720 \">picture 7</a>). They are caused by inadvertent placement of dental silver amalgam restorative material into the oral soft tissues. The most common site for amalgam tattoos is the mandibular arch [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/19\" class=\"abstract_t\">19</a>]. Their appearance may mimic oral melanomas. Visualization of the amalgam dental filling is the key to making the correct diagnosis.</p><p class=\"headingAnchor\" id=\"H7\"><span class=\"h2\">Fordyce spots</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Fordyce spots are benign neoplasms of sebaceous gland etiology. They present as isolated to scattered, white to yellow, 1 to 2 mm discrete papules, particularly prominent on the <span class=\"nowrap\">vermilion/buccal</span> mucosal border (<a href=\"image.htm?imageKey=DERM%2F69406%7EDERM%2F66778\" class=\"graphic graphic_picture graphicRef69406 graphicRef66778 \">picture 8A-B</a>).</p><p class=\"headingAnchor\" id=\"H8\"><span class=\"h2\">Mucoceles</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Mucoceles are fluid filled cavities with mucous glands lining the epithelium. They typically are seen after mild oral trauma as a result of disruption of the salivary gland duct, most frequently of the lower lip (as a result of biting of the lip), but they may also present on the labia. Seen most frequently in patients younger than age 20, mucoceles are variable in size, and may have a gelatinous fluid within that presents clinically as <span class=\"nowrap\">pinkish/blue</span> soft papules or nodules (<a href=\"image.htm?imageKey=DERM%2F70332%7EPEDS%2F75671\" class=\"graphic graphic_picture graphicRef70332 graphicRef75671 \">picture 9A-B</a>).</p><p>Spontaneous rupture can result in complete resolution [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/20\" class=\"abstract_t\">20</a>]. Removal with cryotherapy or excision of the entire cyst can also be performed if the lesions are symptomatic [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/21\" class=\"abstract_t\">21</a>]. CO<sub>2</sub> laser vaporization has also shown good results with a low rate of recurrence, and is an option for clinicians experienced in this modality [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/22\" class=\"abstract_t\">22</a>]. Aspiration alone may initially relieve symptoms, but is rarely indicated except to aid in diagnosis or for short-term relief of irritation, as recurrence is common.</p><p class=\"headingAnchor\" id=\"H84548807\"><span class=\"h2\">Torus palatinus</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Torus palatinus is an exostosis located on the midline of the hard palate. It presents as a bony hard, nodular, lobular, or spindle-shaped mass covered with normal mucosa (<a href=\"image.htm?imageKey=DERM%2F94936\" class=\"graphic graphic_picture graphicRef94936 \">picture 10</a>) [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/23-25\" class=\"abstract_t\">23-25</a>]. Torus palatinus is common, with a prevalence of approximately 20 to 30 percent in the general population.</p><p>The lesion appears during childhood, enlarges slowly over many years, and is asymptomatic. Torus palatinus is typically an incidental finding during routine physical examination. The diagnosis is clinical. However, referral for biopsy and imaging studies may be warranted if the mass is rapidly growing (over weeks or months), is not located on the midline, or has an atypical appearance.</p><p>In most cases, torus palatinus does not require treatment. Surgical removal may be an option if patients develop symptoms or the lesion precludes proper fitting of dentures or prosthetic devices.</p><p class=\"headingAnchor\" id=\"H9\"><span class=\"h1\">INFECTIONS</span></p><p class=\"headingAnchor\" id=\"H10\"><span class=\"h2\">Candidiasis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Oropharyngeal candidiasis or thrush is a common local infection seen in young infants, older adults who wear dentures, diabetics, patients treated with antibiotics, chemotherapy, or radiation therapy, and those with cellular immune deficiency states, such as the acquired immunodeficiency syndrome (AIDS). Patients receiving inhaled glucocorticoids for asthma or rhinitis are also subject to this complication.</p><p>Thrush can manifest in several ways. The pseudomembranous form is the most common and appears as white plaques on the buccal mucosa, palate, tongue, or oropharynx (<a href=\"image.htm?imageKey=DERM%2F82214%7EDERM%2F61040%7EID%2F75887\" class=\"graphic graphic_picture graphicRef82214 graphicRef61040 graphicRef75887 \">picture 11A-C</a>). The atrophic form, which is often found under dentures, is characterized by erythema without plaques (<a href=\"image.htm?imageKey=ID%2F79519\" class=\"graphic graphic_picture graphicRef79519 \">picture 11D</a>) [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/26\" class=\"abstract_t\">26</a>]. Candidiasis may also present with a beefy red tongue and associated soreness. In addition, Candida species can cause angular cheilitis or perl&egrave;che, a painful fissuring at the corners of the mouth. (See <a href=\"topic.htm?path=clinical-manifestations-of-oropharyngeal-and-esophageal-candidiasis\" class=\"medical medical_review\">&quot;Clinical manifestations of oropharyngeal and esophageal candidiasis&quot;</a>.)</p><p>Recurrent, recalcitrant, or extensive disease warrants immune status evaluation and HIV testing. The diagnosis is confirmed by obtaining a KOH prep, scraping the white patches or erosive areas of the mucosa; budding yeasts with or without pseudohyphae are seen.</p><p>Most studies of therapies for oral candidiasis have been performed in patients with HIV or malignancy. Topical therapy is usually effective although relapses in immunosuppressed patients are common. <a href=\"topic.htm?path=nystatin-drug-information\" class=\"drug drug_general\">Nystatin</a> suspension (400,000 to 600,000 units four times per day), nystatin troche (200,000 to 400,000 units four to five times per day), or <a href=\"topic.htm?path=clotrimazole-drug-information\" class=\"drug drug_general\">clotrimazole</a> troche (10 mg troche dissolved five times per day) for 7 to 14 days can be used. Nystatin suspension is the least expensive option; clotrimazole troches are probably more palatable and possibly more effective.</p><p>Options for patients with refractory disease or inability to tolerate topical therapy are discussed in detail elsewhere. (See <a href=\"topic.htm?path=treatment-of-oropharyngeal-and-esophageal-candidiasis\" class=\"medical medical_review\">&quot;Treatment of oropharyngeal and esophageal candidiasis&quot;</a>.)</p><p>Older adult patients with dentures should be reminded to clean their dentures carefully and frequently to reduce the likelihood of developing candidiasis [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/27\" class=\"abstract_t\">27</a>].</p><p class=\"headingAnchor\" id=\"H11\"><span class=\"h2\">Herpes simplex virus</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Herpes simplex virus type 1 (HSV-1) can infect multiple sites of the body, including the oral cavity and perioral area. Herpetic gingivostomatitis is the most common clinical manifestation of primary herpes simplex infection in childhood. The primary infection is often asymptomatic; when symptoms occur they typically include the sudden onset of multiple intraoral vesicular lesions and erosions bordered by an inflammatory, erythematous base (<a href=\"image.htm?imageKey=DERM%2F71764%7EPC%2F73975\" class=\"graphic graphic_picture graphicRef71764 graphicRef73975 \">picture 12A-B</a>). (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-herpes-simplex-virus-type-1-infection\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of herpes simplex virus type 1 infection&quot;</a>.)</p><p>HSV is able to enter, undergo latency, and survive in neural ganglia, thereby preventing elimination of the virus by immune responses. Thus, recurrent infection is common. Most patients (&gt;85 percent) develop prodromal symptoms (eg, pain, burning, tingling) about 24 hours before the appearance of painful lesions at the lip borders [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/28\" class=\"abstract_t\">28</a>]. Precipitating factors include exposure to sunlight, trauma, and emotional stress [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/29\" class=\"abstract_t\">29</a>]. Because primary infection with HSV-1 is often asymptomatic, a recurrence may be the first manifestation of infection.</p><p>Primary episodes of oral HSV tend to involve the buccal mucosa, while recurrent disease is usually confined to the cutaneous surface or keratinized areas [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/30\" class=\"abstract_t\">30</a>]. Young children may have associated fever, lymphadenopathy, drooling, and decreased oral intake. In one study, 3 out of 36 children with herpes gingivostomatitis became dehydrated, requiring hospitalization for intravenous rehydration [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/31\" class=\"abstract_t\">31</a>]. Immunosuppressed individuals can have extensive and persistent intraoral ulcerations due to herpetic infection.</p><p>The diagnosis is confirmed by identifying multinucleated giant cells on a Tzanck smear (these are also seen with varicella zoster virus infection), direct immunofluorescence smear, or by viral culture. The alcohol-wiped vesicle should be gently &quot;unroofed&quot; with a sterile needle; the vesicular fluid can be removed with a sterile cotton swab for viral culture and cells from the base of the lesion may be scraped off gently and placed onto a slide for the Tzanck prep. Slides prepared from scrapings may be examined for herpes antigens via immunofluorescence microscopy. This technique has been made possible by the generation of HSV type-specific monoclonal antibodies that permit identification and typing of isolates in tissue samples. (See <a href=\"topic.htm?path=office-based-dermatologic-diagnostic-procedures#H12\" class=\"medical medical_review\">&quot;Office-based dermatologic diagnostic procedures&quot;, section on 'Tzanck smear'</a> and <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-herpes-simplex-virus-type-1-infection#H27\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of herpes simplex virus type 1 infection&quot;, section on 'Immunofluorescence staining'</a>.)</p><p>The standard treatment regimen involves systemic antiviral therapy (eg, <a href=\"topic.htm?path=acyclovir-drug-information\" class=\"drug drug_general\">acyclovir</a>), pain, and fluid management (see <a href=\"topic.htm?path=treatment-of-herpes-simplex-virus-type-1-infection-in-immunocompetent-patients\" class=\"medical medical_review\">&quot;Treatment of herpes simplex virus type 1 infection in immunocompetent patients&quot;</a>). For comfort care, consider suggesting patients use ice, popsicles, or rinse and expectorate every two hours with <a href=\"topic.htm?path=diphenhydramine-drug-information\" class=\"drug drug_general\">diphenhydramine</a> 12.<span class=\"nowrap\">5/5</span> cc mixed with magnesia-alumina 1:1.</p><p>Most immunocompetent individuals with recurrent herpes labialis do not require treatment other than the occasional use of local analgesics. Attempts to treat recurrent episodes with both topical and oral <a href=\"topic.htm?path=acyclovir-drug-information\" class=\"drug drug_general\">acyclovir</a> have largely been unsuccessful [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/32,33\" class=\"abstract_t\">32,33</a>]. This is mostly due to the difficulty of determining the earliest time of recurrence, since antiviral medication works only during the period of viral replication and thus has little effect if begun after the appearance of lesions. Nevertheless, some patients with an identifiable prodrome may benefit from treatment. In one randomized trial, a single application of acyclovir 50 mg buccal tablets at the first occurrence of prodromal symptoms was more effective than placebo in reducing the rate of recurrence (64 percent versus 74 percent) and the time to recurrence (205 days versus 165 days) [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/34\" class=\"abstract_t\">34</a>].</p><p>Chronic suppression has proven helpful in preventing HSV recrudescence in individuals with frequently recurrent lesions. (See <a href=\"topic.htm?path=treatment-of-herpes-simplex-virus-type-1-infection-in-immunocompetent-patients\" class=\"medical medical_review\">&quot;Treatment of herpes simplex virus type 1 infection in immunocompetent patients&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H12\"><span class=\"h2\">Varicella-zoster virus</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Vesicles and erosions are commonly seen in patients with varicella (chickenpox) (<a href=\"image.htm?imageKey=DERM%2F83137%7EDERM%2F83136\" class=\"graphic graphic_picture graphicRef83137 graphicRef83136 \">picture 13A-B</a>). In patients with herpes zoster, grouped vesicles or erosions may be seen unilaterally on the hard palate (<a href=\"image.htm?imageKey=DERM%2F51866\" class=\"graphic graphic_picture graphicRef51866 \">picture 13C</a>). Other oral areas that may be involved include the buccal mucosa, tongue, and gingiva. (See <a href=\"topic.htm?path=epidemiology-and-pathogenesis-of-varicella-zoster-virus-infection-herpes-zoster\" class=\"medical medical_review\">&quot;Epidemiology and pathogenesis of varicella-zoster virus infection: Herpes zoster&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H13\"><span class=\"h2\">Coxsackie virus</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Infections with coxsackie virus produce both intraoral and <span class=\"nowrap\">palmar/plantar</span> lesions. Coxsackie virus infections most commonly occur in children as oval shaped pale papules with a rim of erythema on the palms and soles, and small aphthae intraorally, otherwise known as hand, foot, and mouth disease (<a href=\"image.htm?imageKey=DERM%2F58566%7EDERM%2F71314%7EID%2F81027%7EPEDS%2F52800%7EDERM%2F53423\" class=\"graphic graphic_picture graphicRef58566 graphicRef71314 graphicRef81027 graphicRef52800 graphicRef53423 \">picture 14A-E</a>). Fever is common along with sore throat and a malaise that often precedes the onset of lesions. Lesions tend to spare the lips and gingiva, in contrast to HSV. Treatment is typically supportive. (See <a href=\"topic.htm?path=enterovirus-and-parechovirus-infections-clinical-features-laboratory-diagnosis-treatment-and-prevention\" class=\"medical medical_review\">&quot;Enterovirus and parechovirus infections: Clinical features, laboratory diagnosis, treatment, and prevention&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H14\"><span class=\"h2\">HIV infection</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Painful mucocutaneous ulceration is one of the most distinctive manifestations of primary HIV-1 infection. Shallow, sharply demarcated ulcers may be found on the oral mucosa, anus, penis, or esophagus [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/35\" class=\"abstract_t\">35</a>]. These lesions may reflect mucocutaneous disease associated with primary HIV infection&nbsp;or coincident sexually transmitted infections, such as herpes simplex virus, syphilis, or chancroid [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/36,37\" class=\"abstract_t\">36,37</a>]. (See <a href=\"topic.htm?path=acute-and-early-hiv-infection-pathogenesis-and-epidemiology\" class=\"medical medical_review\">&quot;Acute and early HIV infection: Pathogenesis and epidemiology&quot;</a>.)</p><p>Oral manifestations of established HIV disease are most commonly due to candidal infections, but many other opportunistic pathogens also can cause oral ulcerations. Antiretroviral treatment has decreased the frequency of HIV-associated oral lesions [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/38\" class=\"abstract_t\">38</a>].</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Oral cryptococcosis and histoplasmosis are non-characteristic and the diagnosis must be made on biopsy.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Mucormycosis (zygomycosis), aspergillosis, and penicilliosis are less common.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Bacterial ulcerations are most commonly caused by bacillary epithelioid angiomatosis, and biopsy is needed to rule out Kaposi's sarcoma. (See <a href=\"topic.htm?path=epidemiology-and-clinical-manifestations-of-bartonella-infections-in-hiv-infected-patients\" class=\"medical medical_review\">&quot;Epidemiology and clinical manifestations of Bartonella infections in HIV-infected patients&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Oral ulcerations have been reported secondary to syphilis, mycobacterium avium intracellulare, Helicobacter pylori, amoeba, and leishmaniasis.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Viral induced ulcerations may erupt due to infection by HSV, cytomegalovirus (CMV), or herpes zoster. Patients with HIV infection tend to have more extensive HSV, while oral ulcers due to CMV are rare. (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-herpes-simplex-virus-type-1-infection\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of herpes simplex virus type 1 infection&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Ulceration in oral neoplasia is seen with Kaposi's sarcoma and non-Hodgkin lymphoma. Involvement of the oral cavity occurs in approximately one-third of patients with Kaposi's sarcoma; the intraoral site most commonly affected is the palate followed by the gingiva [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/39\" class=\"abstract_t\">39</a>]. (See <a href=\"topic.htm?path=aids-related-kaposi-sarcoma-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;AIDS-related Kaposi sarcoma: Clinical manifestations and diagnosis&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Drug reactions (eg, <a href=\"topic.htm?path=foscarnet-drug-information\" class=\"drug drug_general\">foscarnet</a>, interferon, dideoxycytidine) may cause oral ulcerations, agranulocytosis, and toxic epidermal necrolysis in rare cases.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Recurrent aphthous ulcers occur in 0.6 to 13.6 percent of patients with HIV infection, the vast majority of whom will have CD4 cell counts below 100 cells per mm3 [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/40\" class=\"abstract_t\">40</a>]. Healing of oral ulcers has been reported with antiretroviral therapy [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/41\" class=\"abstract_t\">41</a>]. Treatment of aphthous ulcers in HIV disease includes topical antibiotics, glucocorticoids, or analgesics, and oral <a href=\"topic.htm?path=thalidomide-drug-information\" class=\"drug drug_general\">thalidomide</a>. The efficacy of topical treatments for oral aphthous ulcers in patients with HIV infection has not been evaluated in randomized trials [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/42\" class=\"abstract_t\">42</a>]. In two small randomized trials, oral thalidomide, at the dose of 200 <span class=\"nowrap\">mg/day</span> for four to eight weeks, was more effective than placebo in inducing healing of RAS in HIV-infected patients [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/43,44\" class=\"abstract_t\">43,44</a>].</p><p/><p class=\"headingAnchor\" id=\"H15\"><span class=\"h2\">Syphilis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Mucosal involvement may occur with syphilis as split, fissured papules of the oral commissures or oral erosions (<a href=\"image.htm?imageKey=DERM%2F66008%7EDERM%2F72680%7EDERM%2F52729\" class=\"graphic graphic_picture graphicRef66008 graphicRef72680 graphicRef52729 \">picture 15A-C</a>). Look for the more classic papulosquamous eruption involving the palms and soles and condyloma lata involving the anal region. Multiple spirochetes are found in the lesions. (See <a href=\"topic.htm?path=syphilis-epidemiology-pathophysiology-and-clinical-manifestations-in-hiv-uninfected-patients#H8\" class=\"medical medical_review\">&quot;Syphilis: Epidemiology, pathophysiology, and clinical manifestations in HIV-uninfected patients&quot;, section on 'Clinical manifestations'</a>.)</p><p class=\"headingAnchor\" id=\"H16\"><span class=\"h1\">APHTHOUS ULCERATIONS</span></p><p class=\"headingAnchor\" id=\"H757722\"><span class=\"h2\">Recurrent aphthous stomatitis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Aphthae (also called canker sores) are painful oral lesions that appear as localized, shallow, round to oval ulcers with a grayish base (<a href=\"image.htm?imageKey=DERM%2F63475\" class=\"graphic graphic_picture graphicRef63475 \">picture 16</a>). Recurrent aphthous stomatitis (RAS) is the most common cause of mouth ulcers [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/45\" class=\"abstract_t\">45</a>]. RAS may be seen in patients with celiac disease and inflammatory bowel disease and in patients with human immunodeficiency virus (HIV) infection. </p><p class=\"headingAnchor\" id=\"H17\"><span class=\"h3\">Etiology and pathogenesis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The pathogenesis of RAS is not well defined. One hypothesis is that RAS results from a dysregulation in local cell-mediated immunity, with accumulation of subsets of T cells and proinflammatory cytokines [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/46\" class=\"abstract_t\">46</a>].</p><p>Factors that may predispose to the development of RAS include familial tendency, trauma, hormonal factors, and emotional stress [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/47\" class=\"abstract_t\">47</a>]. Vitamin and mineral deficiencies have also been implicated in the pathogenesis of recurrent oral aphthae, particularly deficiency of <a href=\"topic.htm?path=cyanocobalamin-vitamin-b12-drug-information\" class=\"drug drug_general\">vitamin B12</a>. However, in a randomized trial involving 120 patients with RAS, multivitamin supplementation did not reduce the number or duration of RAS episodes [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/48\" class=\"abstract_t\">48</a>]. Although a few observational studies reported a temporary increase of RAS in the first few weeks after stopping smoking [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/49,50\" class=\"abstract_t\">49,50</a>], other studies have not found an association between RAS and smoking [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/51,52\" class=\"abstract_t\">51,52</a>].</p><p>Other causes of aphthae include use of antimetabolites such as <a href=\"topic.htm?path=methotrexate-drug-information\" class=\"drug drug_general\">methotrexate</a> and neutropenia of any cause. (See <a href=\"topic.htm?path=clinical-manifestations-diagnosis-and-prognosis-of-crohn-disease-in-adults\" class=\"medical medical_review\">&quot;Clinical manifestations, diagnosis and prognosis of Crohn disease in adults&quot;</a> and <a href=\"topic.htm?path=major-side-effects-of-low-dose-methotrexate\" class=\"medical medical_review\">&quot;Major side effects of low-dose methotrexate&quot;</a> and <a href=\"topic.htm?path=overview-of-neutropenia-in-children-and-adolescents\" class=\"medical medical_review\">&quot;Overview of neutropenia in children and adolescents&quot;</a> and <a href=\"topic.htm?path=approach-to-the-adult-with-unexplained-neutropenia\" class=\"medical medical_review\">&quot;Approach to the adult with unexplained neutropenia&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H18\"><span class=\"h3\">Clinical presentation and course</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The most common presentation of RAS is the presence of round, clearly defined, small, painful ulcers that heal within 10 to 14 days without scarring [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/45\" class=\"abstract_t\">45</a>]. More severe disease, with larger lesions (&gt;5 mm) that can last for six weeks, is less common. Herpetiform ulcers, which present as multiple small clusters of pinpoint lesions that coalesce to form large irregular ulcers lasting 7 to 10 days, can also occur. Sodium lauryl sulfate, a toothpaste detergent, may prolong the ulcer healing time [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/53\" class=\"abstract_t\">53</a>]. </p><p>Some people have only two to four outbreaks per year, while others may have almost continuous eruptions. Aphthae occur more commonly in childhood and adolescence and become less frequent in adulthood. </p><p class=\"headingAnchor\" id=\"H19\"><span class=\"h3\">Treatment</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The most common treatment for aphthous ulcers includes symptomatic relief with agents such as <a href=\"topic.htm?path=triamcinolone-drug-information\" class=\"drug drug_general\">triamcinolone</a> acetonide in Orabase, <a href=\"topic.htm?path=fluocinonide-drug-information\" class=\"drug drug_general\">fluocinonide</a> gel covered by Orabase, and topical analgesics. These are applied to the ulcer two to four times daily until the ulcer is healed. Early initiation of treatment may result in more rapid healing [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/54\" class=\"abstract_t\">54</a>].</p><p>Chemical cautery can also be used for aphthous ulcers [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/55\" class=\"abstract_t\">55</a>]. Randomized trials with <a href=\"topic.htm?path=silver-nitrate-drug-information\" class=\"drug drug_general\">silver nitrate</a> [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/56\" class=\"abstract_t\">56</a>], or with sulfuric acid with sulfonated phenolics (Debacterol) [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/57\" class=\"abstract_t\">57</a>], suggest that cautery can lead to more rapid improvement in pain, although it does not appear to speed overall healing. Lesions can be numbed with topical <a href=\"topic.htm?path=lidocaine-drug-information\" class=\"drug drug_general\">lidocaine</a> prior to chemical cautery, and patients should rinse with water for several minutes after the procedure.</p><p>Intralesional or oral glucocorticoids are indicated for recalcitrant lesions or severe disease. <a href=\"topic.htm?path=colchicine-drug-information\" class=\"drug drug_general\">Colchicine</a>, <a href=\"topic.htm?path=dapsone-drug-information\" class=\"drug drug_general\">dapsone</a>, <a href=\"topic.htm?path=pentoxifylline-drug-information\" class=\"drug drug_general\">pentoxifylline</a>, interferon alfa, and levamisole also may have therapeutic value in severe cases of RAS [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/58-61\" class=\"abstract_t\">58-61</a>].</p><p><a href=\"topic.htm?path=thalidomide-drug-information\" class=\"drug drug_general\">Thalidomide</a> has been studied in patients with severe RAS [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/43,44,62-64\" class=\"abstract_t\">43,44,62-64</a>]. In a randomized trial of HIV-infected patients with RAS, treatment with thalidomide, 200 <span class=\"nowrap\">mg/day</span> for four weeks, resulted in healing in 16 of 29 patients in the thalidomide group (55 percent) compared with 2 of 28 patients receiving placebo (7 percent) [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/43\" class=\"abstract_t\">43</a>]. A retrospective study of 92 non-HIV infected patients with RAS (including 16 with Beh&ccedil;et syndrome) reported efficacy of lower doses; at a mean initial dose of 50 <span class=\"nowrap\">mg/day,</span> thalidomide induced complete remission in 85 percent of subjects within 14 days [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/64\" class=\"abstract_t\">64</a>]. Recurrence is common following cessation of therapy [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/62\" class=\"abstract_t\">62</a>]; low maintenance doses of thalidomide may reduce recurrences [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/63,64\" class=\"abstract_t\">63,64</a>].</p><p><a href=\"topic.htm?path=thalidomide-drug-information\" class=\"drug drug_general\">Thalidomide</a> is teratogenic (pregnancy class X). In the United States, thalidomide can only be prescribed through a special distribution program designed to minimize the chance of fetal exposure to the drug (S.T.E.P.S. program; access at www.thalomid.<span class=\"nowrap\">com/steps_program</span>.aspx).</p><p class=\"headingAnchor\" id=\"H21\"><span class=\"h2\">Beh&ccedil;et syndrome</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Beh&ccedil;et syndrome is a neutrophilic inflammatory disorder that presents with recurrent oral and genital ulcerations.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Most, but not all, patients initially manifest oral aphthae that are grossly and histologically similar to common oral ulcers; however, they tend to be more extensive and often multiple (<a href=\"image.htm?imageKey=RHEUM%2F76223\" class=\"graphic graphic_picture graphicRef76223 \">picture 17</a>). Healing of the oral ulcerations is typically spontaneous within one to three weeks; although with recurrent lesions, many patients will have ulcers present almost constantly.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Genital lesions occur in about 75 percent of patients with Beh&ccedil;et syndrome. They are similar in appearance to the oral aphthae.</p><p/><p>Recurrent oral ulcers (three times per year) are required for the diagnosis of Beh&ccedil;et syndrome, in addition to two other clinical findings (recurrent genital ulcers, eye lesions, skin lesions, or a positive pathergy test [24 to 48 hours after oblique insertion of a 20 to 25 gauge needle]) (<a href=\"image.htm?imageKey=RHEUM%2F54762\" class=\"graphic graphic_table graphicRef54762 \">table 1</a>) [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/65\" class=\"abstract_t\">65</a>]. (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-behcet-syndrome\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of Beh&ccedil;et syndrome&quot;</a>.)</p><p>The mucocutaneous manifestations of Beh&ccedil;et syndrome can be treated with oral <a href=\"topic.htm?path=colchicine-drug-information\" class=\"drug drug_general\">colchicine</a>, topical anesthetics, topical or intralesional corticosteroids, or systemic glucocorticoids [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/66\" class=\"abstract_t\">66</a>]. <a href=\"topic.htm?path=thalidomide-drug-information\" class=\"drug drug_general\">Thalidomide</a> and <a href=\"topic.htm?path=dapsone-drug-information\" class=\"drug drug_general\">dapsone</a> have also been shown to be effective. (See <a href=\"topic.htm?path=treatment-of-behcet-syndrome\" class=\"medical medical_review\">&quot;Treatment of Beh&ccedil;et syndrome&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H22\"><span class=\"h2\">Complex aphthosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Complex aphthosis is the term used to describe the occurrence of recurrent large oral ulcers in conjunction with genital lesions in the absence of other criteria for Beh&ccedil;et syndrome [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/67,68\" class=\"abstract_t\">67,68</a>]. Other syndromes associated with both oral and genital lesions are the MAGIC syndrome (mouth and genital ulcers with inflamed cartilage), FAPA (fever, aphthosis, pharyngitis, and adenitis) syndrome, and cyclic neutropenia (see <a href=\"topic.htm?path=cyclic-neutropenia\" class=\"medical medical_review\">&quot;Cyclic neutropenia&quot;</a>). Infectious cases of oral and vulvar aphthae include Yersinia enterocolitis, tuberculous enterocolitis, and typhoid fever.</p><p class=\"headingAnchor\" id=\"H32997956\"><span class=\"h2\">Nicorandil-induced ulceration</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Nicorandil is a potassium channel activator used in the treatment of angina pectoris. Its use has been associated with the development of skin and mucosal ulcerations [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/69,70\" class=\"abstract_t\">69,70</a>]. Painful oral ulcerations have been reported in 0.4 to 5 percent of patients taking nicorandil [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/70,71\" class=\"abstract_t\">70,71</a>]. The mechanism by which nicorandil induces cutaneous or mucosal ulcerations is unknown. Oral ulcers can occur weeks to months after starting treatment with any dose of the drug. Lesions resolve spontaneously in a few weeks upon withdrawal of the offending drug [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/70,72,73\" class=\"abstract_t\">70,72,73</a>].</p><p class=\"headingAnchor\" id=\"H24\"><span class=\"h1\">AUTOIMMUNE DISEASES</span></p><p class=\"headingAnchor\" id=\"H25\"><span class=\"h2\">Systemic lupus erythematosus</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Mucus membrane involvement occurs in up to 50 percent of patients with systemic lupus erythematosus (SLE) [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/74\" class=\"abstract_t\">74</a>]. Oral disease can involve the lips and oral mucosa. Discoid lip lesions, characterized as keratotic papules or plaques with pigment alteration, scale, photosensitivity, and atrophy, may be present in up to 25 percent of patients with discoid or subacute lupus erythematosus. Irregularly shaped raised white plaques, silvery white scarred lesions, areas of erythema, and punched out erosions or ulcers with surrounding erythema may appear on the soft or hard palate (<a href=\"image.htm?imageKey=RHEUM%2F63605\" class=\"graphic graphic_picture graphicRef63605 \">picture 18</a>). (See <a href=\"topic.htm?path=overview-of-cutaneous-lupus-erythematosus\" class=\"medical medical_review\">&quot;Overview of cutaneous lupus erythematosus&quot;</a>.)</p><p>In contrast with the discoid lesions that tend to be painful, the oral ulcers are usually painless. There is no apparent association between the presence of such ulcers and systemic activity.</p><p>The diagnosis is based upon the histologic finding on of a lesion biopsy of hyperkeratosis, focal liquefaction degeneration of the basal layer, and a lichenoid infiltrate [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/75,76\" class=\"abstract_t\">75,76</a>]. Treatment of lip lesions includes topical or intralesional glucocorticoids; antimalarials are used for oral ulcerations [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/77\" class=\"abstract_t\">77</a>]. New oral lesions that develop on the buccal mucosa in a patient with SLE who is being treated with an antimalarial drug may represent a lichenoid drug eruption secondary to the antimalarial agent. (See <a href=\"topic.htm?path=overview-of-cutaneous-lupus-erythematosus\" class=\"medical medical_review\">&quot;Overview of cutaneous lupus erythematosus&quot;</a> and <a href=\"topic.htm?path=lichenoid-drug-eruption-drug-induced-lichen-planus\" class=\"medical medical_review\">&quot;Lichenoid drug eruption (drug-induced lichen planus)&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H26\"><span class=\"h2\">Bullous pemphigoid</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Bullous pemphigoid is an autoimmune blistering disorder. Lesions commonly occur in the flexural areas, groin, and axillae. Oral involvement consisting of intact bullae or erosions occurs in about one-third of cases but is rarely the presenting feature. Skin lesions may consist of bullae or urticarial plaques. (See <a href=\"topic.htm?path=clinical-features-and-diagnosis-of-bullous-pemphigoid-and-mucous-membrane-pemphigoid#H53290498\" class=\"medical medical_review\">&quot;Clinical features and diagnosis of bullous pemphigoid and mucous membrane pemphigoid&quot;, section on 'Bullous pemphigoid'</a>.)</p><p>The diagnosis is made on routine and direct immunofluorescence testing of lesional and perilesional skin, respectively. Standard therapy remains oral glucocorticoids, although many other agents are also effective.</p><p class=\"headingAnchor\" id=\"H27\"><span class=\"h2\">Mucous membrane pemphigoid</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Mucous membrane pemphigoid includes a heterogeneous group of chronic inflammatory blistering diseases that affect oral, ocular, pharyngeal, laryngeal, genital, or anal mucosa. Oropharyngeal involvement predominates. Oral lesions include desquamative gingivitis and bullae with a tendency to scar (<a href=\"image.htm?imageKey=DERM%2F77654\" class=\"graphic graphic_picture graphicRef77654 \">picture 19</a>). Significant ocular and upper airway involvement also can occur.</p><p>The diagnosis is made on routine and direct immunofluorescence testing of lesional and perilesional skin, respectively, along with the appropriate clinical findings. Potent immunosuppressants are often necessary to control this disease. (See <a href=\"topic.htm?path=clinical-features-and-diagnosis-of-bullous-pemphigoid-and-mucous-membrane-pemphigoid#H53290512\" class=\"medical medical_review\">&quot;Clinical features and diagnosis of bullous pemphigoid and mucous membrane pemphigoid&quot;, section on 'Mucous membrane pemphigoid'</a>.)</p><p class=\"headingAnchor\" id=\"H338636\"><span class=\"h2\">Epidermolysis bullosa acquisita</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Epidermolysis bullosa acquisita is a rare autoimmune bullous disease presenting with blisters that are localized predominantly at sites of trauma and heal with scarring and milia. Erosions and blisters may occur in the mouth, larynx, and esophagus. (See <a href=\"topic.htm?path=epidermolysis-bullosa-acquisita\" class=\"medical medical_review\">&quot;Epidermolysis bullosa acquisita&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H28\"><span class=\"h2\">Pemphigus vulgaris</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Pemphigus vulgaris is characterized by flaccid bullae that typically begin in the oropharynx and then may spread to involve the skin, with a predilection for the scalp, face, chest, axillae, and groin (<a href=\"image.htm?imageKey=DERM%2F57924\" class=\"graphic graphic_picture graphicRef57924 \">picture 20</a>). The bullae rupture easily, so that the patient often presents with only painful erosions and no intact bullae. One variant, paraneoplastic pemphigus, tends to markedly involve the oral and ocular mucosa.</p><p>The pathogenesis, clinical manifestations, diagnosis, and treatment of pemphigus vulgaris are discussed separately. (See <a href=\"topic.htm?path=pathogenesis-clinical-manifestations-and-diagnosis-of-pemphigus\" class=\"medical medical_review\">&quot;Pathogenesis, clinical manifestations, and diagnosis of pemphigus&quot;</a> and <a href=\"topic.htm?path=initial-management-of-pemphigus-vulgaris-and-pemphigus-foliaceus\" class=\"medical medical_review\">&quot;Initial management of pemphigus vulgaris and pemphigus foliaceus&quot;</a> and <a href=\"topic.htm?path=management-of-refractory-pemphigus-vulgaris-and-pemphigus-foliaceus\" class=\"medical medical_review\">&quot;Management of refractory pemphigus vulgaris and pemphigus foliaceus&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H5099311\"><span class=\"h2\">Paraneoplastic pemphigus</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Paraneoplastic pemphigus (PNP) is a severe paraneoplastic mucocutaneous blistering disorder most often associated with lymphoproliferative disorders [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/78,79\" class=\"abstract_t\">78,79</a>]. Erosive, painful mucositis is uniformly present in patients with PNP, and in its absence, the diagnosis should not be considered. Oral involvement is most common, and patients develop a painful, erosive stomatitis that characteristically involves the tongue (<a href=\"image.htm?imageKey=DERM%2F59594%7EDERM%2F79518%7EDERM%2F54382\" class=\"graphic graphic_picture graphicRef59594 graphicRef79518 graphicRef54382 \">picture 21A-C</a>). Oral erosions are the initial disease manifestation in almost one-half of patients [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/80\" class=\"abstract_t\">80</a>]. </p><p>Paraneoplastic pemphigus is discussed separately. (See <a href=\"topic.htm?path=paraneoplastic-pemphigus\" class=\"medical medical_review\">&quot;Paraneoplastic pemphigus&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H29\"><span class=\"h1\">ERYTHEMA MULTIFORME AND STEVENS-JOHNSON SYNDROME</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Erythema multiforme and Stevens-Johnson syndrome are hypersensitivity reactions that often present with both skin lesions and mucosal involvement (<a href=\"image.htm?imageKey=DERM%2F68153%7EDERM%2F62370%7EDERM%2F68682%7EEM%2F76141%7EEM%2F73805\" class=\"graphic graphic_picture graphicRef68153 graphicRef62370 graphicRef68682 graphicRef76141 graphicRef73805 \">picture 22A-E</a>). Erythema multiforme is frequently related to herpes simplex infections, but also may be caused by other infections (eg, Mycoplasma pneumoniae) or medications, or may be idiopathic. Stevens-Johnson syndrome is most commonly induced by drugs. Target skin lesions are a characteristic feature of erythema multiforme; erythematous, purpuric macules and skin detachment may occur in Stevens-Johnson syndrome. (See <a href=\"topic.htm?path=pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme#H5\" class=\"medical medical_review\">&quot;Pathogenesis, clinical features, and diagnosis of erythema multiforme&quot;, section on 'Clinical manifestations'</a> and <a href=\"topic.htm?path=stevens-johnson-syndrome-and-toxic-epidermal-necrolysis-pathogenesis-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;Stevens-Johnson syndrome and toxic epidermal necrolysis: Pathogenesis, clinical manifestations, and diagnosis&quot;</a>.)</p><p>Mucosal involvement is seen in more than 90 percent of patients with erythema multiforme and Stevens-Johnson syndrome [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/81\" class=\"abstract_t\">81</a>]. When oral lesions are the primary feature, erythema and edema of the lips along with intraoral bullae may occur. The bullae often rupture, leaving painful friable raw surfaces and even hemorrhagic crusts. Pain is a prominent feature when oral lesions are present.</p><p>The management of these disorders is discussed separately. (See <a href=\"topic.htm?path=treatment-of-erythema-multiforme\" class=\"medical medical_review\">&quot;Treatment of erythema multiforme&quot;</a> and <a href=\"topic.htm?path=stevens-johnson-syndrome-and-toxic-epidermal-necrolysis-management-prognosis-and-long-term-sequelae\" class=\"medical medical_review\">&quot;Stevens-Johnson syndrome and toxic epidermal necrolysis: Management, prognosis, and long-term sequelae&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H30\"><span class=\"h1\">MISCELLANEOUS</span></p><p class=\"headingAnchor\" id=\"H1840503\"><span class=\"h2\">Lichen planus</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Oral mucosal involvement may occur with lichen planus as an isolated event or in conjunction with cutaneous or genital disease. The presentation of oral lichen planus may vary from lace-like white patches (Wickham striae) on the buccal mucosa to erosions on the gingival margin (<a href=\"image.htm?imageKey=DERM%2F76338%7EDERM%2F54143%7EDERM%2F62826\" class=\"graphic graphic_picture graphicRef76338 graphicRef54143 graphicRef62826 \">picture 23A-C</a>). Lesions are often painful and interfere with oral intake. Oral lichen planus tends to be chronic, and may increase the risk for oral cancer. (See <a href=\"topic.htm?path=oral-lichen-planus-pathogenesis-clinical-features-and-diagnosis\" class=\"medical medical_review\">&quot;Oral lichen planus: Pathogenesis, clinical features, and diagnosis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H5099414\"><span class=\"h2\">Burning mouth syndrome</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Burning mouth syndrome is an uncommon disorder affecting predominantly postmenopausal women, characterized by a persistent intraoral burning sensation for which no medical or dental cause can be found [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/82,83\" class=\"abstract_t\">82,83</a>]. Before making the diagnosis, it is important to exclude other mucosal disease, including xerostomia and allergic contact stomatitis. (See <a href=\"topic.htm?path=overview-of-craniofacial-pain#H1651832\" class=\"medical medical_review\">&quot;Overview of craniofacial pain&quot;, section on 'Burning mouth syndrome'</a>.)</p><p class=\"headingAnchor\" id=\"H72957244\"><span class=\"h2\">Telangiectasias secondary to hereditary hemorrhagic telangiectasia</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In patients with hereditary hemorrhagic telangiectasia, mucosal telangiectasias can occur anywhere along the gastrointestinal tract and are frequently visible on the lips, tongue, and oral mucosa (<a href=\"image.htm?imageKey=DERM%2F96711%7EDERM%2F96712\" class=\"graphic graphic_picture graphicRef96711 graphicRef96712 \">picture 24A-B</a>) [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/84,85\" class=\"abstract_t\">84,85</a>]. They generally develop by the age of 30 years and increase in number over time. Bleeding can occur but rarely requires medical intervention. (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-hereditary-hemorrhagic-telangiectasia-osler-weber-rendu-syndrome\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome)&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H59929804\"><span class=\"h2\">Atrophic glossitis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Atrophic glossitis is an inflammatory disorder of the tongue that leads to the atrophy of the filiform papillae. The tongue appears smooth, glossy, and erythematous (<a href=\"image.htm?imageKey=DERM%2F85872%7EPEDS%2F54472\" class=\"graphic graphic_picture graphicRef85872 graphicRef54472 \">picture 25A-B</a>). Causes of atrophic glossitis include [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/86-88\" class=\"abstract_t\">86-88</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Nutritional deficiencies (iron, <a href=\"topic.htm?path=cyanocobalamin-vitamin-b12-drug-information\" class=\"drug drug_general\">vitamin B12</a>, <a href=\"topic.htm?path=folic-acid-drug-information\" class=\"drug drug_general\">folic acid</a>) (see <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-vitamin-b12-and-folate-deficiency\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of vitamin B12 and folate deficiency&quot;</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Dry mouth (sicca symptoms) (see <a href=\"topic.htm?path=diagnosis-and-classification-of-sjogrens-syndrome#H19529178\" class=\"medical medical_review\">&quot;Diagnosis and classification of Sj&ouml;gren's syndrome&quot;, section on 'Dry eye and mouth in older adults'</a> and <a href=\"topic.htm?path=diagnosis-and-classification-of-sjogrens-syndrome#H720851742\" class=\"medical medical_review\">&quot;Diagnosis and classification of Sj&ouml;gren's syndrome&quot;, section on 'Epidemiology'</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Sj&ouml;gren syndrome (see <a href=\"topic.htm?path=treatment-of-dry-mouth-and-other-non-ocular-sicca-symptoms-in-sjogrens-syndrome\" class=\"medical medical_review\">&quot;Treatment of dry mouth and other non-ocular sicca symptoms in Sj&ouml;gren's syndrome&quot;</a> and <a href=\"topic.htm?path=clinical-manifestations-of-sjogrens-syndrome-exocrine-gland-disease\" class=\"medical medical_review\">&quot;Clinical manifestations of Sj&ouml;gren's syndrome: Exocrine gland disease&quot;</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Oral Candida infection (see <a href=\"#H10\" class=\"local\">'Candidiasis'</a> above)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Protein-calorie malnutrition in older adults (see <a href=\"topic.htm?path=geriatric-nutrition-nutritional-issues-in-older-adults\" class=\"medical medical_review\">&quot;Geriatric nutrition: Nutritional issues in older adults&quot;</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Celiac disease (see <a href=\"topic.htm?path=diagnosis-of-celiac-disease-in-adults\" class=\"medical medical_review\">&quot;Diagnosis of celiac disease in adults&quot;</a>)</p><p/><p>Patients with atrophic glossitis often complain of a burning sensation and increased sensitivity when eating acidic or salty foods. Treatment is directed at the underlying condition. </p><p class=\"headingAnchor\" id=\"H59929819\"><span class=\"h2\">Fissured tongue</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Fissured tongue is a benign condition of unknown etiology usually seen in adults. Deep grooves are located on the midline or evenly distributed on the tongue surface (<a href=\"image.htm?imageKey=DERM%2F85871\" class=\"graphic graphic_picture graphicRef85871 \">picture 26</a>). Fissured tongue is also seen in patients with Down syndrome or Melkersson-Rosenthal syndrome (a rare syndrome characterized by the triad of fissured tongue, facial palsy, and granulomatous cheilitis) [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/89,90\" class=\"abstract_t\">89,90</a>]. (See <a href=\"topic.htm?path=down-syndrome-clinical-features-and-diagnosis#H2688998\" class=\"medical medical_review\">&quot;Down syndrome: Clinical features and diagnosis&quot;, section on 'Skin disorders'</a> and <a href=\"topic.htm?path=bells-palsy-pathogenesis-clinical-features-and-diagnosis-in-adults#H49717029\" class=\"medical medical_review\">&quot;Bell's palsy: Pathogenesis, clinical features, and diagnosis in adults&quot;, section on 'Melkersson-Rosenthal syndrome'</a>.) </p><p>Patients with fissured tongue are generally asymptomatic. The condition is permanent and does not require treatment unless the patient gets irritation from entrapped debris in the fissures. In such cases, brushing the affected area or using an oral irrigator may provide benefit.</p><p class=\"headingAnchor\" id=\"H31\"><span class=\"h2\">Black tongue</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Hyperpigmentation of the tongue and oral mucosa is commonly seen in dark-skinned individuals. Less common causes of tongue hyperpigmentation include drugs (eg, tetracyclines, <a href=\"topic.htm?path=linezolid-drug-information\" class=\"drug drug_general\">linezolid</a>, <a href=\"topic.htm?path=bismuth-subsalicylate-drug-information\" class=\"drug drug_general\">bismuth subsalicylate</a>, antidepressants, proton pump inhibitors, interferon), Addison disease (<a href=\"image.htm?imageKey=DERM%2F67179\" class=\"graphic graphic_picture graphicRef67179 \">picture 27</a>), Laugier-Hunziker disease, or pellagra [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/91-94\" class=\"abstract_t\">91-94</a>].</p><p class=\"headingAnchor\" id=\"H338200\"><span class=\"h2\">Black hairy tongue</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Black hairy tongue (lingua villosa nigra) is a benign condition associated with antibiotic use, candida albicans infection, or poor oral hygiene. Patients have elongated filiform papillae or, in pseudohairy tongue, a yellowish white to brown dorsal tongue surface (<a href=\"image.htm?imageKey=DERM%2F76664\" class=\"graphic graphic_picture graphicRef76664 \">picture 28</a>). Therapy consists of brushing that area of the tongue with a soft-bristle toothbrush and toothpaste two to three times per day [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/36\" class=\"abstract_t\">36</a>].</p><p class=\"headingAnchor\" id=\"H57121454\"><span class=\"h2\">Pigmented fungiform papillae of the tongue</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Fungiform papillae are scattered on the tongue surface, predominantly on the anterior and lateral aspects, and are usually pink or red in color. Individuals with darker skin tones may show pigmented spots on the tongue due to melanin deposition on the tips of the fungiform papillae (<a href=\"image.htm?imageKey=DERM%2F93385\" class=\"graphic graphic_picture graphicRef93385 \">picture 29</a>) [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/95\" class=\"abstract_t\">95</a>]. Lesions usually appear during the second or third decade of life and are typically asymptomatic [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/96-98\" class=\"abstract_t\">96-98</a>]. Histologic examination reveals submucosal melanophages within the fungiform papillae in the absence of inflammation.</p><p class=\"headingAnchor\" id=\"H32\"><span class=\"h2\">Geographic tongue</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Geographic tongue (benign migratory glossitis) is a disorder of unknown etiology that affects the epithelium of the tongue [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/99\" class=\"abstract_t\">99</a>]. Local loss of filiform papillae leads to ulcer-like lesions that appear as erythematous patches on the dorsal tongue with circumferential white polycyclic borders (<a href=\"image.htm?imageKey=PEDS%2F74654%7EDERM%2F79512\" class=\"graphic graphic_picture graphicRef74654 graphicRef79512 \">picture 30A-B</a>). Lesions can change location, pattern, and size within minutes to hours, and patients may have numerous exacerbations and remissions over time. Exacerbations are usually asymptomatic, although some patients complain of oral discomfort, burning, or foreign body sensations.</p><p>The differential diagnosis includes candidiasis, psoriasis, Reiter syndrome, lichen planus, leukoplakia, systemic lupus erythematosus, herpes simplex virus, and drug reaction [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/99\" class=\"abstract_t\">99</a>]. The diagnosis is typically based on the clinical presentation and biopsy is not necessary. However, biopsy may be reassuring in unclear cases. The histology of involved areas is similar to pustular psoriasis.</p><p>No therapy is needed since patients are usually asymptomatic or have only mild symptoms. Symptomatic treatments that have been reported but are unproven include fluids, <a href=\"topic.htm?path=acetaminophen-paracetamol-drug-information\" class=\"drug drug_general\">acetaminophen</a>, mouth rinsing with a topical anesthetic agent, antihistamines, anxiolytics, <a href=\"topic.htm?path=tacrolimus-drug-information\" class=\"drug drug_general\">tacrolimus</a>, and corticosteroids [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/100-102\" class=\"abstract_t\">100-102</a>] </p><p class=\"headingAnchor\" id=\"H33\"><span class=\"h2\">Cheilitis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Cheilitis is an acute or chronic inflammation of the lips characterized by erythema, scaling, fissuring, and itching or burning. Factors that may precipitate or aggravate the condition include wind-burns, contact with irritants or allergens, and some medications, such as topical or systemic retinoids. Chronic lip licking is a common cause in young children as the saliva causes a repeated irritant dermatitis. Secondary infection resulting in impetigo is common in young children. </p><p>The clinical manifestations, diagnosis, and treatment of acute and chronic forms of cheilitis are reviewed in detail separately. (See <a href=\"topic.htm?path=cheilitis\" class=\"medical medical_review\">&quot;Cheilitis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H34\"><span class=\"h2\">Contact and irritant stomatitis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Contact or irritant stomatitis is a less common cause of oral lesions, but may present with a wide variety of manifestations, including erosions, ulcerations, lichenoid-like reactions, leukoplakic lesions, or only erythema (<a href=\"image.htm?imageKey=DERM%2F58869\" class=\"graphic graphic_picture graphicRef58869 \">picture 31</a>) [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/103\" class=\"abstract_t\">103</a>]. Allergic reactions are primarily due to metallic mercury, cinnamon aldehyde, and gold salts, among others (<a href=\"image.htm?imageKey=PC%2F54139\" class=\"graphic graphic_table graphicRef54139 \">table 2</a>).</p><p>Lip and perioral involvement is seen when the offending agent is chewed or applied topically. Repetitive friction, particularly in relationship to dental appliances, may result in traumatic ulcers. Leukoplakic-like lesions can occur due to repeated friction from poorly fitting prostheses, cheek sucking, or with the use of oral tobacco. Lichenoid, lace-like, localized, buccal mucosal patches may occur secondary to amalgam. Symptoms usually outweigh clinical disease.</p><p>Burning mouth syndrome is most commonly seen in middle aged women and is not necessarily related to any allergies. Contact urticaria is seen most commonly due to allergies to dental materials or natural rubber latex, and anaphylaxis can occur. Food related inflammation may present with prominent lip swelling. (See <a href=\"topic.htm?path=overview-of-craniofacial-pain#H1651832\" class=\"medical medical_review\">&quot;Overview of craniofacial pain&quot;, section on 'Burning mouth syndrome'</a>.)</p><p class=\"headingAnchor\" id=\"H35\"><span class=\"h2\">Dental erosions/gingival hyperplasia</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>It is important to perform a thorough dental examination even in the absence of oral complaints. Patients on chronic antiepileptic medications may develop gingival hyperplasia, particularly those on <a href=\"topic.htm?path=phenytoin-drug-information\" class=\"drug drug_general\">phenytoin</a>, as can patients taking <a href=\"topic.htm?path=cyclosporine-ciclosporin-drug-information\" class=\"drug drug_general\">cyclosporine</a> and <a href=\"topic.htm?path=nifedipine-drug-information\" class=\"drug drug_general\">nifedipine</a> (<a href=\"image.htm?imageKey=DERM%2F82641\" class=\"graphic graphic_picture graphicRef82641 \">picture 32</a>). Dental erosions can occur from even mild systemic illness, such as chronic gastroesophageal reflux, and once established erosions can predispose to aspiration syndromes [<a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/104\" class=\"abstract_t\">104</a>].</p><p class=\"headingAnchor\" id=\"H36\"><span class=\"h2\">Inherited epidermolysis bullosa</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Epidermolysis bullosa describes a group of rare inherited diseases with the common finding of epithelial fragility. Affected sites occur most commonly in areas of trauma and friction. Milder forms do not typically involve the mucosae, while more severe manifestations involve the oral, pharyngeal, and esophageal mucosa and tooth formation. (See <a href=\"topic.htm?path=the-genodermatoses#H13\" class=\"medical medical_review\">&quot;The genodermatoses&quot;, section on 'Epidermolysis bullosa'</a>.)</p><p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\"><span class=\"h1\">INFORMATION FOR PATIENTS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>UpToDate offers two types of patient education materials, &quot;The Basics&quot; and &quot;Beyond the Basics.&quot; The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &quot;patient info&quot; and the keyword(s) of interest.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Basics topic (see <a href=\"topic.htm?path=mouth-sores-the-basics\" class=\"medical medical_basics\">&quot;Patient education: Mouth sores (The Basics)&quot;</a> and <a href=\"topic.htm?path=leukoplakia-the-basics\" class=\"medical medical_basics\">&quot;Patient education: Leukoplakia (The Basics)&quot;</a>)</p><p/><p class=\"headingAnchor\" id=\"H7432083\"><span class=\"h1\">SUMMARY</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Dermatologic lesions of the mouth and gums include a wide variety of disease processes that can present with similar appearing lesions. (See <a href=\"#H1\" class=\"local\">'Introduction'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Tumors and precancerous lesions include squamous cell carcinoma (<a href=\"image.htm?imageKey=DERM%2F81810%7EDERM%2F59057%7EDERM%2F74239\" class=\"graphic graphic_picture graphicRef81810 graphicRef59057 graphicRef74239 \">picture 1A-C</a>), leukoplakia (<a href=\"image.htm?imageKey=DERM%2F81049%7EDERM%2F60939%7EDERM%2F72711\" class=\"graphic graphic_picture graphicRef81049 graphicRef60939 graphicRef72711 \">picture 2A-C</a>), and melanoma. Lesions that can mimic tumors of the oral mucosa include amalgam tattoos (<a href=\"image.htm?imageKey=DERM%2F51720\" class=\"graphic graphic_picture graphicRef51720 \">picture 7</a>), Fordyce spots (<a href=\"image.htm?imageKey=DERM%2F69406%7EDERM%2F66778\" class=\"graphic graphic_picture graphicRef69406 graphicRef66778 \">picture 8A-B</a>), and mucocele (<a href=\"image.htm?imageKey=DERM%2F70332%7EPEDS%2F75671\" class=\"graphic graphic_picture graphicRef70332 graphicRef75671 \">picture 9A-B</a>). (See <a href=\"#H2\" class=\"local\">'Tumors (and lesions that mimic)'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Infections of the oral mucosa include candidiasis (<a href=\"image.htm?imageKey=DERM%2F82214%7EDERM%2F61040%7EID%2F75887%7EID%2F79519\" class=\"graphic graphic_picture graphicRef82214 graphicRef61040 graphicRef75887 graphicRef79519 \">picture 11A-D</a>), herpes simplex virus infection (<a href=\"image.htm?imageKey=DERM%2F71764%7EPC%2F73975\" class=\"graphic graphic_picture graphicRef71764 graphicRef73975 \">picture 12A-B</a>), varicella-zoster infection (<a href=\"image.htm?imageKey=DERM%2F83137%7EDERM%2F83136%7EDERM%2F51866\" class=\"graphic graphic_picture graphicRef83137 graphicRef83136 graphicRef51866 \">picture 13A-C</a>), coxsackie virus infection (hand, foot, and mouth disease) (<a href=\"image.htm?imageKey=DERM%2F58566%7EDERM%2F71314%7EID%2F81027%7EPEDS%2F52800%7EDERM%2F53423\" class=\"graphic graphic_picture graphicRef58566 graphicRef71314 graphicRef81027 graphicRef52800 graphicRef53423 \">picture 14A-E</a>), HIV infection, and primary (<a href=\"image.htm?imageKey=DERM%2F82771\" class=\"graphic graphic_picture graphicRef82771 \">picture 33</a>) or secondary syphilis (<a href=\"image.htm?imageKey=DERM%2F66008%7EDERM%2F72680%7EDERM%2F52729\" class=\"graphic graphic_picture graphicRef66008 graphicRef72680 graphicRef52729 \">picture 15A-C</a>). (See <a href=\"#H9\" class=\"local\">'Infections'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Aphthous ulcerations include recurrent aphthous stomatitis, the most common cause of oral ulcers (<a href=\"image.htm?imageKey=DERM%2F63475\" class=\"graphic graphic_picture graphicRef63475 \">picture 16</a>), Beh&ccedil;et syndrome (<a href=\"image.htm?imageKey=RHEUM%2F76223\" class=\"graphic graphic_picture graphicRef76223 \">picture 17</a>), and complex aphthosis.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Autoimmune diseases with involvement of the oral mucosa include systemic lupus erythematosus (<a href=\"image.htm?imageKey=RHEUM%2F63605\" class=\"graphic graphic_picture graphicRef63605 \">picture 18</a>), bullous pemphigoid (<a href=\"image.htm?imageKey=DERM%2F66179\" class=\"graphic graphic_picture graphicRef66179 \">picture 34</a>), mucous membrane pemphigoid (<a href=\"image.htm?imageKey=DERM%2F77654\" class=\"graphic graphic_picture graphicRef77654 \">picture 19</a>), epidermolysis bullosa acquisita, and pemphigus vulgaris (<a href=\"image.htm?imageKey=DERM%2F57924\" class=\"graphic graphic_picture graphicRef57924 \">picture 20</a>). (See <a href=\"#H24\" class=\"local\">'Autoimmune diseases'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Oral involvement occurs in more than 90 percent of patients with erythema multiforme and Stevens-Johnson syndrome with erythema, edema, bullae, and erosions of the lips and oral mucosa (<a href=\"image.htm?imageKey=DERM%2F68153%7EDERM%2F62370%7EDERM%2F68682%7EEM%2F76141%7EEM%2F73805\" class=\"graphic graphic_picture graphicRef68153 graphicRef62370 graphicRef68682 graphicRef76141 graphicRef73805 \">picture 22A-E</a>). (See <a href=\"#H29\" class=\"local\">'Erythema multiforme and Stevens-Johnson syndrome'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Other disorders of the lips and mouth include oral lichen planus (<a href=\"image.htm?imageKey=DERM%2F76338%7EDERM%2F54143%7EDERM%2F62826\" class=\"graphic graphic_picture graphicRef76338 graphicRef54143 graphicRef62826 \">picture 23A-C</a>), tongue hyperpigmentation (<a href=\"image.htm?imageKey=DERM%2F67179\" class=\"graphic graphic_picture graphicRef67179 \">picture 27</a>), atrophic glossitis (<a href=\"image.htm?imageKey=PEDS%2F54472\" class=\"graphic graphic_picture graphicRef54472 \">picture 25B</a>), fissured tongue (see <a href=\"#H59929819\" class=\"local\">'Fissured tongue'</a> above), geographic tongue (<a href=\"image.htm?imageKey=PEDS%2F74654%7EDERM%2F79512\" class=\"graphic graphic_picture graphicRef74654 graphicRef79512 \">picture 30A-B</a>), actinic cheilitis (<a href=\"image.htm?imageKey=DERM%2F68057\" class=\"graphic graphic_picture graphicRef68057 \">picture 35</a>), angular cheilitis (perl&egrave;che) (<a href=\"image.htm?imageKey=DERM%2F55357\" class=\"graphic graphic_picture graphicRef55357 \">picture 36</a>), contact and irritant stomatitis (<a href=\"image.htm?imageKey=DERM%2F58869\" class=\"graphic graphic_picture graphicRef58869 \">picture 31</a>), dental erosions and gingival hypertrophy (<a href=\"image.htm?imageKey=DERM%2F82641\" class=\"graphic graphic_picture graphicRef82641 \">picture 32</a>). (See <a href=\"#H30\" class=\"local\">'Miscellaneous'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Severe forms of epidermolysis bullosa, a group of rare inherited diseases characterized by skin fragility, may be associated with blistering and scarring of the oral mucosa and teeth abnormalities. (See <a href=\"#H36\" class=\"local\">'Inherited epidermolysis bullosa'</a> above.)</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/1\" class=\"nounderline abstract_t\">Morgan R, Tsang J, Harrington N, Fook L. Survey of hospital doctors' attitudes and knowledge of oral conditions in older patients. Postgrad Med J 2001; 77:392.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/2\" class=\"nounderline abstract_t\">Gillison ML, Broutian T, Pickard RK, et al. Prevalence of oral HPV infection in the United States, 2009-2010. JAMA 2012; 307:693.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/3\" class=\"nounderline abstract_t\">Cianfriglia F, Di Gregorio DA, Cianfriglia C, et al. Incidence of human papillomavirus infection in oral leukoplakia. Indications for a viral aetiology. J Exp Clin Cancer Res 2006; 25:21.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/4\" class=\"nounderline abstract_t\">Lee JJ, Hong WK, Hittelman WN, et al. Predicting cancer development in oral leukoplakia: ten years of translational research. Clin Cancer Res 2000; 6:1702.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/5\" class=\"nounderline abstract_t\">Shiu MN, Chen TH, Chang SH, Hahn LJ. Risk factors for leukoplakia and malignant transformation to oral carcinoma: a leukoplakia cohort in Taiwan. Br J Cancer 2000; 82:1871.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/6\" class=\"nounderline abstract_t\">van der Waal I, Schepman KP, van der Meij EH. A modified classification and staging system for oral leukoplakia. Oral Oncol 2000; 36:264.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/7\" class=\"nounderline abstract_t\">Grady D, Greene J, Daniels TE, et al. Oral mucosal lesions found in smokeless tobacco users. J Am Dent Assoc 1990; 121:117.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/8\" class=\"nounderline abstract_t\">Gillenwater AM, Vigneswaran N, Fatani H, et al. Proliferative verrucous leukoplakia (PVL): a review of an elusive pathologic entity! Adv Anat Pathol 2013; 20:416.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/9\" class=\"nounderline abstract_t\">Bagan J, Scully C, Jimenez Y, Martorell M. Proliferative verrucous leukoplakia: a concise update. Oral Dis 2010; 16:328.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/10\" class=\"nounderline abstract_t\">Pentenero M, Meleti M, Vescovi P, Gandolfo S. Oral proliferative verrucous leucoplakia: are there particular features for such an ambiguous entity? A systematic review. Br J Dermatol 2014; 170:1039.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/11\" class=\"nounderline abstract_t\">Issrani R, Prabhu N, Keluskar V. Oral proliferative verrucous leukoplakia: A case report with an update. Contemp Clin Dent 2013; 4:258.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/12\" class=\"nounderline abstract_t\">Schoelch ML, Sekandari N, Regezi JA, Silverman S Jr. Laser management of oral leukoplakias: a follow-up study of 70 patients. Laryngoscope 1999; 109:949.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/13\" class=\"nounderline abstract_t\">Poveda-Roda R, Bagan JV, Jim&eacute;nez-Soriano Y, et al. Retinoids and proliferative verrucous leukoplakia (PVL). A preliminary study. Med Oral Patol Oral Cir Bucal 2010; 15:e3.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/14\" class=\"nounderline abstract_t\">Silverman S Jr, Gorsky M. Proliferative verrucous leukoplakia: a follow-up study of 54 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997; 84:154.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/15\" class=\"nounderline abstract_t\">DeMatos P, Tyler DS, Seigler HF. Malignant melanoma of the mucous membranes: a review of 119 cases. Ann Surg Oncol 1998; 5:733.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/16\" class=\"nounderline abstract_t\">Eisen D, Voorhees JJ. Oral melanoma and other pigmented lesions of the oral cavity. J Am Acad Dermatol 1991; 24:527.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/17\" class=\"nounderline abstract_t\">Kaugars GE, Heise AP, Riley WT, et al. Oral melanotic macules. A review of 353 cases. Oral Surg Oral Med Oral Pathol 1993; 76:59.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/18\" class=\"nounderline abstract_t\">Vaughan V, Ferringer T. Granular cell tumor. Cutis 2014; 94:275, 279.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/19\" class=\"nounderline abstract_t\">Owens BM, Johnson WW, Schuman NJ. Oral amalgam pigmentations (tattoos): a retrospective study. Quintessence Int 1992; 23:805.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/20\" class=\"nounderline abstract_t\">Chi AC, Lambert PR 3rd, Richardson MS, Neville BW. Oral mucoceles: a clinicopathologic review of 1,824 cases, including unusual variants. J Oral Maxillofac Surg 2011; 69:1086.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/21\" class=\"nounderline abstract_t\">B&ouml;hler-Sommeregger K, Kutschera-Hienert G. Cryosurgical management of myxoid cysts. J Dermatol Surg Oncol 1988; 14:1405.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/22\" class=\"nounderline abstract_t\">Huang IY, Chen CM, Kao YH, Worthington P. Treatment of mucocele of the lower lip with carbon dioxide laser. J Oral Maxillofac Surg 2007; 65:855.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/23\" class=\"nounderline abstract_t\">Ladizinski B, Lee KC. A nodular protuberance on the hard palate. JAMA 2014; 311:1558.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/24\" class=\"nounderline abstract_t\">Loukas M, Hulsberg P, Tubbs RS, et al. The tori of the mouth and ear: a review. Clin Anat 2013; 26:953.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/25\" class=\"nounderline abstract_t\">Garc&iacute;a-Garc&iacute;a AS, Mart&iacute;nez-Gonz&aacute;lez JM, G&oacute;mez-Font R, et al. Current status of the torus palatinus and torus mandibularis. Med Oral Patol Oral Cir Bucal 2010; 15:e353.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/26\" class=\"nounderline abstract_t\">Budtz-J&oslash;rgensen E. Oral mucosal lesions associated with the wearing of removable dentures. J Oral Pathol 1981; 10:65.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/27\" class=\"nounderline abstract_t\">Kanli A, Demirel F, Sezgin Y. Oral candidosis, denture cleanliness and hygiene habits in an elderly population. Aging Clin Exp Res 2005; 17:502.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/28\" class=\"nounderline abstract_t\">Corey L, Spear PG. Infections with herpes simplex viruses (1). N Engl J Med 1986; 314:686.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/29\" class=\"nounderline abstract_t\">Young SK, Rowe NH, Buchanan RA. A clinical study for the control of facial mucocutaneous herpes virus infections. I. Characterization of natural history in a professional school population. Oral Surg Oral Med Oral Pathol 1976; 41:498.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/30\" class=\"nounderline abstract_t\">Hebert AA, Lopez MD. Oral lesions in pediatric patients. Adv Dermatol 1997; 12:169.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/31\" class=\"nounderline abstract_t\">Amir J, Harel L, Smetana Z, Varsano I. The natural history of primary herpes simplex type 1 gingivostomatitis in children. Pediatr Dermatol 1999; 16:259.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/32\" class=\"nounderline abstract_t\">Spruance SL, Crumpacker CS, Schnipper LE, et al. Early, patient-initiated treatment of herpes labialis with topical 10% acyclovir. Antimicrob Agents Chemother 1984; 25:553.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/33\" class=\"nounderline abstract_t\">Raborn GW, Martel AY, Grace MG, McGaw WT. Oral acyclovir in prevention of herpes labialis. A randomized, double-blind, multi-centered clinical trial. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998; 85:55.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/34\" class=\"nounderline abstract_t\">Bieber T, Chosidow O, Bodsworth N, et al. Efficacy and safety of aciclovir mucoadhesive buccal tablet in immunocompetent patients with labial herpes (LIP Trial): a double-blind, placebo-controlled, self-initiated trial. J Drugs Dermatol 2014; 13:791.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/35\" class=\"nounderline abstract_t\">Lapins J, Gaines H, Lindb&auml;ck S, et al. Skin and mucosal characteristics of symptomatic primary HIV-1 infection. AIDS Patient Care STDS 1997; 11:67.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/36\" class=\"nounderline abstract_t\">Sarti GM, Haddy RI, Schaffer D, Kihm J. Black hairy tongue. Am Fam Physician 1990; 41:1751.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/37\" class=\"nounderline abstract_t\">Lima Gda S, Silva GF, Gomes AP, et al. Diclofenac in hyaluronic acid gel: an alternative treatment for actinic cheilitis. J Appl Oral Sci 2010; 18:533.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/38\" class=\"nounderline abstract_t\">Ram&iacute;rez-Amador V, Esquivel-Pedraza L, Sierra-Madero J, et al. The Changing Clinical Spectrum of Human Immunodeficiency Virus (HIV)-Related Oral Lesions in 1,000 Consecutive Patients: A 12-Year Study in a Referral Center in Mexico. Medicine (Baltimore) 2003; 82:39.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/39\" class=\"nounderline abstract_t\">Nichols CM, Flaitz CM, Hicks MJ. Treating Kaposi's lesions in the HIV-infected patient. J Am Dent Assoc 1993; 124:78.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/40\" class=\"nounderline abstract_t\">Reichart PA. Oral ulcerations in HIV infection. Oral Dis 1997; 3 Suppl 1:S180.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/41\" class=\"nounderline abstract_t\">Alegre M, Dalmau J, Domingo P, et al. Successful treatment of major oral aphthous ulcers in HIV-1 infection after highly active antiretroviral therapy. Int J Infect Dis 2007; 11:278.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/42\" class=\"nounderline abstract_t\">Kuteyi T, Okwundu CI. Topical treatments for HIV-related oral ulcers. Cochrane Database Syst Rev 2012; 1:CD007975.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/43\" class=\"nounderline abstract_t\">Jacobson JM, Greenspan JS, Spritzler J, et al. Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group. N Engl J Med 1997; 336:1487.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/44\" class=\"nounderline abstract_t\">Ramirez-Amador VA, Esquivel-Pedraza L, Ponce-de-Leon S, et al. Thalidomide as therapy for human immunodeficiency virus-related oral ulcers: a double-blind placebo-controlled clinical trial. Clin Infect Dis 1999; 28:892.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/45\" class=\"nounderline abstract_t\">Ship JA. Recurrent aphthous stomatitis. An update. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996; 81:141.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/46\" class=\"nounderline abstract_t\">Dalghous AM, Freysdottir J, Fortune F. Expression of cytokines, chemokines, and chemokine receptors in oral ulcers of patients with Behcet's disease (BD) and recurrent aphthous stomatitis is Th1-associated, although Th2-association is also observed in patients with BD. Scand J Rheumatol 2006; 35:472.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/47\" class=\"nounderline abstract_t\">Akintoye SO, Greenberg MS. Recurrent aphthous stomatitis. Dent Clin North Am 2014; 58:281.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/48\" class=\"nounderline abstract_t\">Lalla RV, Choquette LE, Feinn RS, et al. Multivitamin therapy for recurrent aphthous stomatitis: a randomized, double-masked, placebo-controlled trial. J Am Dent Assoc 2012; 143:370.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/49\" class=\"nounderline abstract_t\">Marako&#287;lu K, Sezer RE, Toker HC, Marako&#287;lu I. The recurrent aphthous stomatitis frequency in the smoking cessation people. Clin Oral Investig 2007; 11:149.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/50\" class=\"nounderline abstract_t\">Ussher M, West R, Steptoe A, McEwen A. Increase in common cold symptoms and mouth ulcers following smoking cessation. Tob Control 2003; 12:86.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/51\" class=\"nounderline abstract_t\">Bratel J, Hakeberg M. Anamnestic findings from patients with recurrent aphthous stomatitis. Swed Dent J 2014; 38:143.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/52\" class=\"nounderline abstract_t\">Sawair FA. Does smoking really protect from recurrent aphthous stomatitis? Ther Clin Risk Manag 2010; 6:573.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/53\" class=\"nounderline abstract_t\">Shim YJ, Choi JH, Ahn HJ, Kwon JS. Effect of sodium lauryl sulfate on recurrent aphthous stomatitis: a randomized controlled clinical trial. Oral Dis 2012; 18:655.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/54\" class=\"nounderline abstract_t\">Liu C, Zhou Z, Liu G, et al. Efficacy and safety of dexamethasone ointment on recurrent aphthous ulceration. Am J Med 2012; 125:292.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/55\" class=\"nounderline abstract_t\">Soylu &Ouml;zler G. Silver nitrate cauterization: a treatment option for aphthous stomatitis. J Craniomaxillofac Surg 2014; 42:e281.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/56\" class=\"nounderline abstract_t\">Alidaee MR, Taheri A, Mansoori P, Ghodsi SZ. Silver nitrate cautery in aphthous stomatitis: a randomized controlled trial. Br J Dermatol 2005; 153:521.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/57\" class=\"nounderline abstract_t\">Rhodus NL, Bereuter J. An evaluation of a chemical cautery agent and an anti-inflammatory ointment for the treatment of recurrent aphthous stomatitis: a pilot study. Quintessence Int 1998; 29:769.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/58\" class=\"nounderline abstract_t\">Ruah CB, Stram JR, Chasin WD. Treatment of severe recurrent aphthous stomatitis with colchicine. Arch Otolaryngol Head Neck Surg 1988; 114:671.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/59\" class=\"nounderline abstract_t\">Thornhill MH, Baccaglini L, Theaker E, Pemberton MN. A randomized, double-blind, placebo-controlled trial of pentoxifylline for the treatment of recurrent aphthous stomatitis. Arch Dermatol 2007; 143:463.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/60\" class=\"nounderline abstract_t\">Lynde CB, Bruce AJ, Rogers RS 3rd. Successful treatment of complex aphthosis with colchicine and dapsone. Arch Dermatol 2009; 145:273.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/61\" class=\"nounderline abstract_t\">Altenburg A, Abdel-Naser MB, Seeber H, et al. Practical aspects of management of recurrent aphthous stomatitis. J Eur Acad Dermatol Venereol 2007; 21:1019.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/62\" class=\"nounderline abstract_t\">Revuz J, Guillaume JC, Janier M, et al. Crossover study of thalidomide vs placebo in severe recurrent aphthous stomatitis. Arch Dermatol 1990; 126:923.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/63\" class=\"nounderline abstract_t\">Bonnetblanc JM, Royer C, Bedane C. Thalidomide and recurrent aphthous stomatitis: a follow-up study. Dermatology 1996; 193:321.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/64\" class=\"nounderline abstract_t\">Hello M, Barbarot S, Bastuji-Garin S, et al. Use of thalidomide for severe recurrent aphthous stomatitis: a multicenter cohort analysis. Medicine (Baltimore) 2010; 89:176.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/65\" class=\"nounderline abstract_t\">Criteria for diagnosis of Beh&ccedil;et's disease. International Study Group for Beh&ccedil;et's Disease. Lancet 1990; 335:1078.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/66\" class=\"nounderline abstract_t\">Sakane T, Takeno M, Suzuki N, Inaba G. Beh&ccedil;et's disease. N Engl J Med 1999; 341:1284.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/67\" class=\"nounderline abstract_t\">McCarty MA, Garton RA, Jorizzo JL. Complex aphthosis and Beh&ccedil;et's disease. Dermatol Clin 2003; 21:41.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/68\" class=\"nounderline abstract_t\">Jorizzo JL, Taylor RS, Schmalstieg FC, et al. Complex aphthosis: a forme fruste of Beh&ccedil;et's syndrome? J Am Acad Dermatol 1985; 13:80.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/69\" class=\"nounderline abstract_t\">Lee MT, Lin HY, Lee SH, et al. Risk of skin ulcerations associated with oral nicorandil therapy: a population-based study. Br J Dermatol 2015; 173:498.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/70\" class=\"nounderline abstract_t\">Webster K, Godbold P. Nicorandil induced oral ulceration. Br Dent J 2005; 198:619.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/71\" class=\"nounderline abstract_t\">Marquart-Elbaz C, Lipsker D, Grosshans E, Cribier B. [Oral ulcers induced by nicorandil: prevalence and clinicopathological aspects]. Ann Dermatol Venereol 1999; 126:587.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/72\" class=\"nounderline abstract_t\">Yamamoto K, Matsusue Y, Horita S, et al. Nicorandil-induced oral ulceration: report of 3 cases and review of the Japanese literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011; 112:754.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/73\" class=\"nounderline abstract_t\">Scully C, Azul AM, Crighton A, et al. Nicorandil can induce severe oral ulceration. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001; 91:189.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/74\" class=\"nounderline abstract_t\">Sultan SM, Ioannou Y, Isenberg DA. A review of gastrointestinal manifestations of systemic lupus erythematosus. Rheumatology (Oxford) 1999; 38:917.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/75\" class=\"nounderline abstract_t\">Louren&ccedil;o SV, de Carvalho FR, Boggio P, et al. Lupus erythematosus: clinical and histopathological study of oral manifestations and immunohistochemical profile of the inflammatory infiltrate. J Cutan Pathol 2007; 34:558.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/76\" class=\"nounderline abstract_t\">Ranginwala AM, Chalishazar MM, Panja P, et al. Oral discoid lupus erythematosus: A study of twenty-one cases. J Oral Maxillofac Pathol 2012; 16:368.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/77\" class=\"nounderline abstract_t\">Callen JP. Oral manifestations of collagen vascular disease. Semin Cutan Med Surg 1997; 16:323.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/78\" class=\"nounderline abstract_t\">Frew JW, Murrell DF. Paraneoplastic pemphigus (paraneoplastic autoimmune multiorgan syndrome): clinical presentations and pathogenesis. Dermatol Clin 2011; 29:419.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/79\" class=\"nounderline abstract_t\">Anhalt GJ. Paraneoplastic pemphigus. J Investig Dermatol Symp Proc 2004; 9:29.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/80\" class=\"nounderline abstract_t\">Billet SE, Grando SA, Pittelkow MR. Paraneoplastic autoimmune multiorgan syndrome: review of the literature and support for a cytotoxic role in pathogenesis. Autoimmunity 2006; 39:617.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/81\" class=\"nounderline abstract_t\">Revuz J, Penso D, Roujeau JC, et al. Toxic epidermal necrolysis. Clinical findings and prognosis factors in 87 patients. Arch Dermatol 1987; 123:1160.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/82\" class=\"nounderline abstract_t\">Kohorst JJ, Bruce AJ, Torgerson RR, et al. A population-based study of the incidence of burning mouth syndrome. Mayo Clin Proc 2014; 89:1545.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/83\" class=\"nounderline abstract_t\">Sun A, Wu KM, Wang YP, et al. Burning mouth syndrome: a review and update. J Oral Pathol Med 2013; 42:649.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/84\" class=\"nounderline abstract_t\">Olitsky SE. Picture of the month. Telangiectases secondary to hereditary hemorrhagic telangiectasia. Arch Pediatr Adolesc Med 2011; 165:275.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/85\" class=\"nounderline abstract_t\">Shovlin CL. Hereditary haemorrhagic telangiectasia: pathophysiology, diagnosis and treatment. Blood Rev 2010; 24:203.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/86\" class=\"nounderline abstract_t\">Reamy BV, Derby R, Bunt CW. Common tongue conditions in primary care. Am Fam Physician 2010; 81:627.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/87\" class=\"nounderline abstract_t\">Pastore L, Carroccio A, Compilato D, et al. Oral manifestations of celiac disease. J Clin Gastroenterol 2008; 42:224.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/88\" class=\"nounderline abstract_t\">B&oslash;hmer T, Mow&eacute; M. The association between atrophic glossitis and protein-calorie malnutrition in old age. Age Ageing 2000; 29:47.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/89\" class=\"nounderline abstract_t\">Daneshpazhooh M, Nazemi TM, Bigdeloo L, Yoosefi M. Mucocutaneous findings in 100 children with Down syndrome. Pediatr Dermatol 2007; 24:317.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/90\" class=\"nounderline abstract_t\">Rose AE, Leger M, Chu J, Meehan S. Cheilitis granulomatosa. Dermatol Online J 2011; 17:15.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/91\" class=\"nounderline abstract_t\">Jover-Diaz F, Cuadrado-Pastor JM, Talents-Bolos A, Martin-Gonzalez C. Black tongue associated with linezolid. Am J Ther 2010; 17:e115.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/92\" class=\"nounderline abstract_t\">Guinovart RM, Carrascosa JM, Bielsa I, et al. A black tongue in a young woman. Clin Exp Dermatol 2011; 36:429.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/93\" class=\"nounderline abstract_t\">Cohen PR. Black tongue secondary to bismuth subsalicylate: case report and review of exogenous causes of macular lingual pigmentation. J Drugs Dermatol 2009; 8:1132.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/94\" class=\"nounderline abstract_t\">Ma DL, Vano-Galvan S. Hyperpigmentation in Laugier-Hunziker syndrome. CMAJ 2011; 183:1402.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/95\" class=\"nounderline abstract_t\">Holzwanger JM, Rudolph RI, Heaton CL. Pigmented fungiform papillae of the tongue: a common variant of oral pigmentation. Int J Dermatol 1974; 13:403.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/96\" class=\"nounderline abstract_t\">Romiti R, Molina De Medeiros L. Pigmented fungiform papillae of the tongue. Pediatr Dermatol 2010; 27:398.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/97\" class=\"nounderline abstract_t\">Werchniak AE, Storm CA, Dinulos JG. Hyperpigmented patches on the tongue of a young girl. Pigmented fungiform papillae of the tongue. Arch Dermatol 2004; 140:1275.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/98\" class=\"nounderline abstract_t\">Al-Fagaan F, Joseph B. A case of pigmented fungiform papillae of the tongue in a Middle Eastern woman. Med Princ Pract 2014; 23:167.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/99\" class=\"nounderline abstract_t\">Assimakopoulos D, Patrikakos G, Fotika C, Elisaf M. Benign migratory glossitis or geographic tongue: an enigmatic oral lesion. Am J Med 2002; 113:751.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/100\" class=\"nounderline abstract_t\">Sigal MJ, Mock D. Symptomatic benign migratory glossitis: report of two cases and literature review. Pediatr Dent 1992; 14:392.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/101\" class=\"nounderline abstract_t\">Brooks JK, Balciunas BA. Geographic stomatitis: review of the literature and report of five cases. J Am Dent Assoc 1987; 115:421.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/102\" class=\"nounderline abstract_t\">Ishibashi M, Tojo G, Watanabe M, et al. Geographic tongue treated with topical tacrolimus. J Dermatol Case Rep 2010; 4:57.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/103\" class=\"nounderline abstract_t\">Tosti A, Piraccini BM, Peluso AM. Contact and irritant stomatitis. Semin Cutan Med Surg 1997; 16:314.</a></li><li><a href=\"https://www.uptodate.com/contents/oral-lesions/abstract/104\" class=\"nounderline abstract_t\">Lazarchik DA, Filler SJ. Effects of gastroesophageal reflux on the oral cavity. Am J Med 1997; 103:107S.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 5572 Version 33.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H7432083\"><span>SUMMARY</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">TUMORS (AND LESIONS THAT MIMIC)</a><ul><li><a href=\"#H3\" id=\"outline-link-H3\">Squamous cell carcinoma</a></li><li><a href=\"#H4\" id=\"outline-link-H4\">Leukoplakia</a><ul><li><a href=\"#H60611044\" id=\"outline-link-H60611044\">- Oral proliferative verrucous leukoplakia</a></li></ul></li><li><a href=\"#H5\" id=\"outline-link-H5\">Melanoma</a></li><li><a href=\"#H78046470\" id=\"outline-link-H78046470\">Granular cell tumor</a></li><li><a href=\"#H6\" id=\"outline-link-H6\">Amalgam tattoos</a></li><li><a href=\"#H7\" id=\"outline-link-H7\">Fordyce spots</a></li><li><a href=\"#H8\" id=\"outline-link-H8\">Mucoceles</a></li><li><a href=\"#H84548807\" id=\"outline-link-H84548807\">Torus palatinus</a></li></ul></li><li><a href=\"#H9\" id=\"outline-link-H9\">INFECTIONS</a><ul><li><a href=\"#H10\" id=\"outline-link-H10\">Candidiasis</a></li><li><a href=\"#H11\" id=\"outline-link-H11\">Herpes simplex virus</a></li><li><a href=\"#H12\" id=\"outline-link-H12\">Varicella-zoster virus</a></li><li><a href=\"#H13\" id=\"outline-link-H13\">Coxsackie virus</a></li><li><a href=\"#H14\" id=\"outline-link-H14\">HIV infection</a></li><li><a href=\"#H15\" id=\"outline-link-H15\">Syphilis</a></li></ul></li><li><a href=\"#H16\" id=\"outline-link-H16\">APHTHOUS ULCERATIONS</a><ul><li><a href=\"#H757722\" id=\"outline-link-H757722\">Recurrent aphthous stomatitis</a><ul><li><a href=\"#H17\" id=\"outline-link-H17\">- Etiology and pathogenesis</a></li><li><a href=\"#H18\" id=\"outline-link-H18\">- Clinical presentation and course</a></li><li><a href=\"#H19\" id=\"outline-link-H19\">- Treatment</a></li></ul></li><li><a href=\"#H21\" id=\"outline-link-H21\">Beh&ccedil;et syndrome</a></li><li><a href=\"#H22\" id=\"outline-link-H22\">Complex aphthosis</a></li><li><a href=\"#H32997956\" id=\"outline-link-H32997956\">Nicorandil-induced ulceration</a></li></ul></li><li><a href=\"#H24\" id=\"outline-link-H24\">AUTOIMMUNE DISEASES</a><ul><li><a href=\"#H25\" id=\"outline-link-H25\">Systemic lupus erythematosus</a></li><li><a href=\"#H26\" id=\"outline-link-H26\">Bullous pemphigoid</a></li><li><a href=\"#H27\" id=\"outline-link-H27\">Mucous membrane pemphigoid</a></li><li><a href=\"#H338636\" id=\"outline-link-H338636\">Epidermolysis bullosa acquisita</a></li><li><a href=\"#H28\" id=\"outline-link-H28\">Pemphigus vulgaris</a></li><li><a href=\"#H5099311\" id=\"outline-link-H5099311\">Paraneoplastic pemphigus</a></li></ul></li><li><a href=\"#H29\" id=\"outline-link-H29\">ERYTHEMA MULTIFORME AND STEVENS-JOHNSON SYNDROME</a></li><li><a href=\"#H30\" id=\"outline-link-H30\">MISCELLANEOUS</a><ul><li><a href=\"#H1840503\" id=\"outline-link-H1840503\">Lichen planus</a></li><li><a href=\"#H5099414\" id=\"outline-link-H5099414\">Burning mouth syndrome</a></li><li><a href=\"#H72957244\" id=\"outline-link-H72957244\">Telangiectasias secondary to hereditary hemorrhagic telangiectasia</a></li><li><a href=\"#H59929804\" id=\"outline-link-H59929804\">Atrophic glossitis</a></li><li><a href=\"#H59929819\" id=\"outline-link-H59929819\">Fissured tongue</a></li><li><a href=\"#H31\" id=\"outline-link-H31\">Black tongue</a></li><li><a href=\"#H338200\" id=\"outline-link-H338200\">Black hairy tongue</a></li><li><a href=\"#H57121454\" id=\"outline-link-H57121454\">Pigmented fungiform papillae of the tongue</a></li><li><a href=\"#H32\" id=\"outline-link-H32\">Geographic tongue</a></li><li><a href=\"#H33\" id=\"outline-link-H33\">Cheilitis</a></li><li><a href=\"#H34\" id=\"outline-link-H34\">Contact and irritant stomatitis</a></li><li><a href=\"#H35\" id=\"outline-link-H35\">Dental erosions/gingival hyperplasia</a></li><li><a href=\"#H36\" id=\"outline-link-H36\">Inherited epidermolysis bullosa</a></li></ul></li><li><a href=\"#PATIENT_INFORMATION\" id=\"outline-link-H23373771\">INFORMATION FOR PATIENTS</a></li><li><a href=\"#H7432083\" id=\"outline-link-H7432083\">SUMMARY</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DERM/5572|PIC\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"PICTURES\">PICTURES</a></div><ul><li><a href=\"image.htm?imageKey=DERM/81810\" class=\"graphic graphic_picture\">- Squamous cell carcinoma - tongue</a></li><li><a href=\"image.htm?imageKey=DERM/59057\" class=\"graphic graphic_picture\">- Squamous cell carcinoma - lip</a></li><li><a href=\"image.htm?imageKey=DERM/74239\" class=\"graphic graphic_picture\">- Squamous cell carcinoma - gingiva</a></li><li><a href=\"image.htm?imageKey=DERM/81049\" class=\"graphic graphic_picture\">- Leukoplakia - buccal</a></li><li><a href=\"image.htm?imageKey=DERM/60939\" class=\"graphic graphic_picture\">- Leukoplakia - palate</a></li><li><a href=\"image.htm?imageKey=DERM/72711\" class=\"graphic graphic_picture\">- Leukoplakia - tongue</a></li><li><a href=\"image.htm?imageKey=DERM/95480\" class=\"graphic graphic_picture\">- Proliferative verrucous leukoplakia gingiva</a></li><li><a href=\"image.htm?imageKey=DERM/95484\" class=\"graphic graphic_picture\">- Oral proliferative verrucous leukoplakia histo1</a></li><li><a href=\"image.htm?imageKey=DERM/100363\" class=\"graphic graphic_picture\">- Granular cell tumor tongue</a></li><li><a href=\"image.htm?imageKey=DERM/100364\" class=\"graphic graphic_picture\">- Granular cell tumor tongue histo</a></li><li><a href=\"image.htm?imageKey=DERM/51720\" class=\"graphic graphic_picture\">- Amalgam tattoo</a></li><li><a href=\"image.htm?imageKey=DERM/69406\" class=\"graphic graphic_picture\">- Fordyce spots - buccal</a></li><li><a href=\"image.htm?imageKey=DERM/66778\" class=\"graphic graphic_picture\">- Fordyce spots - lip</a></li><li><a href=\"image.htm?imageKey=DERM/70332\" class=\"graphic graphic_picture\">- Mucocele - lower lip</a></li><li><a href=\"image.htm?imageKey=PEDS/75671\" class=\"graphic graphic_picture\">- Mucoceles</a></li><li><a href=\"image.htm?imageKey=DERM/94936\" class=\"graphic graphic_picture\">- Torus palatinus</a></li><li><a href=\"image.htm?imageKey=DERM/82214\" class=\"graphic graphic_picture\">- Oral candidiasis - tongue</a></li><li><a href=\"image.htm?imageKey=DERM/61040\" class=\"graphic graphic_picture\">- Oral candidiasis - palate</a></li><li><a href=\"image.htm?imageKey=ID/75887\" class=\"graphic graphic_picture\">- Oropharyngeal candidiasis</a></li><li><a href=\"image.htm?imageKey=ID/79519\" class=\"graphic graphic_picture\">- Candida denture stomatitis</a></li><li><a href=\"image.htm?imageKey=DERM/71764\" class=\"graphic graphic_picture\">- Herpes simplex - oral</a></li><li><a href=\"image.htm?imageKey=PC/73975\" class=\"graphic graphic_picture\">- Herpes simplex labialis</a></li><li><a href=\"image.htm?imageKey=DERM/83137\" class=\"graphic graphic_picture\">- Chickenpox oral 2</a></li><li><a href=\"image.htm?imageKey=DERM/83136\" class=\"graphic graphic_picture\">- Chickenpox oral 1</a></li><li><a href=\"image.htm?imageKey=DERM/51866\" class=\"graphic graphic_picture\">- Herpes zoster - palate</a></li><li><a href=\"image.htm?imageKey=DERM/58566\" class=\"graphic graphic_picture\">- Hand-foot-and-mouth disease - buccal</a></li><li><a href=\"image.htm?imageKey=DERM/71314\" class=\"graphic graphic_picture\">- Hand-foot-and-mouth disease - tongue</a></li><li><a href=\"image.htm?imageKey=ID/81027\" class=\"graphic graphic_picture\">- Enanthem in Coxsackie infection</a></li><li><a href=\"image.htm?imageKey=PEDS/52800\" class=\"graphic graphic_picture\">- Hand-foot-and-mouth disease - lip and hand</a></li><li><a href=\"image.htm?imageKey=DERM/53423\" class=\"graphic graphic_picture\">- Hand-foot-and-mouth disease - foot</a></li><li><a href=\"image.htm?imageKey=DERM/66008\" class=\"graphic graphic_picture\">- Secondary syphilis - oral fissure</a></li><li><a href=\"image.htm?imageKey=DERM/72680\" class=\"graphic graphic_picture\">- Secondary syphilis - oral mucosa</a></li><li><a href=\"image.htm?imageKey=DERM/52729\" class=\"graphic graphic_picture\">- Secondary syphilis - tongue</a></li><li><a href=\"image.htm?imageKey=DERM/63475\" class=\"graphic graphic_picture\">- Aphthous ulcers</a></li><li><a href=\"image.htm?imageKey=RHEUM/76223\" class=\"graphic graphic_picture\">- Oral aphthae in Beh&ccedil;et's syndrome</a></li><li><a href=\"image.htm?imageKey=RHEUM/63605\" class=\"graphic graphic_picture\">- Mucous membrane lesions in systemic lupus erythematosus</a></li><li><a href=\"image.htm?imageKey=DERM/77654\" class=\"graphic graphic_picture\">- Cicatricial pemphigoid - gingiva</a></li><li><a href=\"image.htm?imageKey=DERM/57924\" class=\"graphic graphic_picture\">- Pemphigus vulgaris - oral</a></li><li><a href=\"image.htm?imageKey=DERM/59594\" class=\"graphic graphic_picture\">- Paraneoplastic pemphigus oral findings</a></li><li><a href=\"image.htm?imageKey=DERM/79518\" class=\"graphic graphic_picture\">- Paraneoplastic pemphigus tongue</a></li><li><a href=\"image.htm?imageKey=DERM/54382\" class=\"graphic graphic_picture\">- Paraneoplastic pemphigus gingiva</a></li><li><a href=\"image.htm?imageKey=DERM/68153\" class=\"graphic graphic_picture\">- Erythema multiforme lip</a></li><li><a href=\"image.htm?imageKey=DERM/62370\" class=\"graphic graphic_picture\">- Erythema multiforme acral</a></li><li><a href=\"image.htm?imageKey=DERM/68682\" class=\"graphic graphic_picture\">- Stevens-Johnson syndrome (SJS)</a></li><li><a href=\"image.htm?imageKey=EM/76141\" class=\"graphic graphic_picture\">- Cutaneous findings of Stevens-Johnson syndrome</a></li><li><a href=\"image.htm?imageKey=EM/73805\" class=\"graphic graphic_picture\">- Mucosal changes in Stevens-Johnson syndrome</a></li><li><a href=\"image.htm?imageKey=DERM/76338\" class=\"graphic graphic_picture\">- Lichen planus - oral Wickham striae</a></li><li><a href=\"image.htm?imageKey=DERM/54143\" class=\"graphic graphic_picture\">- Oral lichen planus - gingiva</a></li><li><a href=\"image.htm?imageKey=DERM/62826\" class=\"graphic graphic_picture\">- Oral lichen planus - erosive</a></li><li><a href=\"image.htm?imageKey=DERM/96711\" class=\"graphic graphic_picture\">- Lip and tongue telangiectasias in HHT</a></li><li><a href=\"image.htm?imageKey=DERM/96712\" class=\"graphic graphic_picture\">- Oral telangiectasias in HHT</a></li><li><a href=\"image.htm?imageKey=DERM/85872\" class=\"graphic graphic_picture\">- Atrophic glossitis 2</a></li><li><a href=\"image.htm?imageKey=PEDS/54472\" class=\"graphic graphic_picture\">- Atrophic glossitis</a></li><li><a href=\"image.htm?imageKey=DERM/85871\" class=\"graphic graphic_picture\">- Fissured tongue 1</a></li><li><a href=\"image.htm?imageKey=DERM/67179\" class=\"graphic graphic_picture\">- Black tongue Addison</a></li><li><a href=\"image.htm?imageKey=DERM/76664\" class=\"graphic graphic_picture\">- Hairy tongue</a></li><li><a href=\"image.htm?imageKey=DERM/93385\" class=\"graphic graphic_picture\">- Pigmented fungiform papillae</a></li><li><a href=\"image.htm?imageKey=PEDS/74654\" class=\"graphic graphic_picture\">- Geographic tongue</a></li><li><a href=\"image.htm?imageKey=DERM/79512\" class=\"graphic graphic_picture\">- Geographic tongue - distal</a></li><li><a href=\"image.htm?imageKey=DERM/58869\" class=\"graphic graphic_picture\">- Contact stomatitis</a></li><li><a href=\"image.htm?imageKey=DERM/82641\" class=\"graphic graphic_picture\">- Gingival hyperplasia</a></li><li><a href=\"image.htm?imageKey=DERM/82771\" class=\"graphic graphic_picture\">- Primary syphilis oral</a></li><li><a href=\"image.htm?imageKey=DERM/66179\" class=\"graphic graphic_picture\">- Bullous pemphigoid oral mucosa</a></li><li><a href=\"image.htm?imageKey=DERM/68057\" class=\"graphic graphic_picture\">- Actinic cheilitis</a></li><li><a href=\"image.htm?imageKey=DERM/55357\" class=\"graphic graphic_picture\">- Angular cheilitis</a></li></ul></li><li><div id=\"DERM/5572|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=RHEUM/54762\" class=\"graphic graphic_table\">- Diagnosis of Beh&ccedil;et's syndrome</a></li><li><a href=\"image.htm?imageKey=PC/54139\" class=\"graphic graphic_table\">- Sources contact stomatitis</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=aids-related-kaposi-sarcoma-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">AIDS-related Kaposi sarcoma: Clinical manifestations and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=acute-and-early-hiv-infection-pathogenesis-and-epidemiology\" class=\"medical medical_review\">Acute and early HIV infection: Pathogenesis and epidemiology</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=approach-to-the-adult-with-unexplained-neutropenia\" class=\"medical medical_review\">Approach to the adult with unexplained neutropenia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=bad-breath\" class=\"medical medical_review\">Bad breath</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=bells-palsy-pathogenesis-clinical-features-and-diagnosis-in-adults\" class=\"medical medical_review\">Bell's palsy: Pathogenesis, clinical features, and diagnosis in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=cheilitis\" class=\"medical medical_review\">Cheilitis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=chemoprevention-and-screening-in-oral-dysplasia-and-squamous-cell-head-and-neck-cancer\" class=\"medical medical_review\">Chemoprevention and screening in oral dysplasia and squamous cell head and neck cancer</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-features-and-diagnosis-of-bullous-pemphigoid-and-mucous-membrane-pemphigoid\" class=\"medical medical_review\">Clinical features and diagnosis of bullous pemphigoid and mucous membrane pemphigoid</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-behcet-syndrome\" class=\"medical medical_review\">Clinical manifestations and diagnosis of Beh&ccedil;et syndrome</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-hereditary-hemorrhagic-telangiectasia-osler-weber-rendu-syndrome\" class=\"medical medical_review\">Clinical manifestations and diagnosis of hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-herpes-simplex-virus-type-1-infection\" class=\"medical medical_review\">Clinical manifestations and diagnosis of herpes simplex virus type 1 infection</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-vitamin-b12-and-folate-deficiency\" class=\"medical medical_review\">Clinical manifestations and diagnosis of vitamin B12 and folate deficiency</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-treatment-of-epstein-barr-virus-infection\" class=\"medical medical_review\">Clinical manifestations and treatment of Epstein-Barr virus infection</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-of-sjogrens-syndrome-exocrine-gland-disease\" class=\"medical medical_review\">Clinical manifestations of Sj&ouml;gren's syndrome: Exocrine gland disease</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-of-oropharyngeal-and-esophageal-candidiasis\" class=\"medical medical_review\">Clinical manifestations of oropharyngeal and esophageal candidiasis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-diagnosis-and-prognosis-of-crohn-disease-in-adults\" class=\"medical medical_review\">Clinical manifestations, diagnosis and prognosis of Crohn disease in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=cyclic-neutropenia\" class=\"medical medical_review\">Cyclic neutropenia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=diagnosis-and-classification-of-sjogrens-syndrome\" class=\"medical medical_review\">Diagnosis and classification of Sj&ouml;gren's syndrome</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=diagnosis-of-celiac-disease-in-adults\" class=\"medical medical_review\">Diagnosis of celiac disease in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=down-syndrome-clinical-features-and-diagnosis\" class=\"medical medical_review\">Down syndrome: Clinical features and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=enterovirus-and-parechovirus-infections-clinical-features-laboratory-diagnosis-treatment-and-prevention\" class=\"medical medical_review\">Enterovirus and parechovirus infections: Clinical features, laboratory diagnosis, treatment, and prevention</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=epidemiology-and-clinical-manifestations-of-bartonella-infections-in-hiv-infected-patients\" class=\"medical medical_review\">Epidemiology and clinical manifestations of Bartonella infections in HIV-infected patients</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=epidemiology-and-pathogenesis-of-varicella-zoster-virus-infection-herpes-zoster\" class=\"medical medical_review\">Epidemiology and pathogenesis of varicella-zoster virus infection: Herpes zoster</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=epidemiology-and-risk-factors-for-head-and-neck-cancer\" class=\"medical medical_review\">Epidemiology and risk factors for head and neck cancer</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=epidemiology-pathogenesis-and-clinical-manifestations-of-odontogenic-infections\" class=\"medical medical_review\">Epidemiology, pathogenesis, and clinical manifestations of odontogenic infections</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=epidermolysis-bullosa-acquisita\" class=\"medical medical_review\">Epidermolysis bullosa acquisita</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=geriatric-nutrition-nutritional-issues-in-older-adults\" class=\"medical medical_review\">Geriatric nutrition: Nutritional issues in older adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=gingivitis-and-periodontitis-in-adults-classification-and-dental-treatment\" class=\"medical medical_review\">Gingivitis and periodontitis in adults: Classification and dental treatment</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=head-and-neck-squamous-cell-carcinogenesis-molecular-and-genetic-alterations\" class=\"medical medical_review\">Head and neck squamous cell carcinogenesis: Molecular and genetic alterations</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=human-papillomavirus-associated-head-and-neck-cancer\" class=\"medical medical_review\">Human papillomavirus associated head and neck cancer</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=initial-management-of-pemphigus-vulgaris-and-pemphigus-foliaceus\" class=\"medical medical_review\">Initial management of pemphigus vulgaris and pemphigus foliaceus</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=initial-surgical-management-of-melanoma-of-the-skin-and-unusual-sites\" class=\"medical medical_review\">Initial surgical management of melanoma of the skin and unusual sites</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=lichenoid-drug-eruption-drug-induced-lichen-planus\" class=\"medical medical_review\">Lichenoid drug eruption (drug-induced lichen planus)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=major-side-effects-of-low-dose-methotrexate\" class=\"medical medical_review\">Major side effects of low-dose methotrexate</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=management-of-refractory-pemphigus-vulgaris-and-pemphigus-foliaceus\" class=\"medical medical_review\">Management of refractory pemphigus vulgaris and pemphigus foliaceus</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=office-based-dermatologic-diagnostic-procedures\" class=\"medical medical_review\">Office-based dermatologic diagnostic procedures</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=oral-lichen-planus-pathogenesis-clinical-features-and-diagnosis\" class=\"medical medical_review\">Oral lichen planus: Pathogenesis, clinical features, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-craniofacial-pain\" class=\"medical medical_review\">Overview of craniofacial pain</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-cutaneous-lupus-erythematosus\" class=\"medical medical_review\">Overview of cutaneous lupus erythematosus</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-neutropenia-in-children-and-adolescents\" class=\"medical medical_review\">Overview of neutropenia in children and adolescents</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-the-diagnosis-and-staging-of-head-and-neck-cancer\" class=\"medical medical_review\">Overview of the diagnosis and staging of head and neck cancer</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-treatment-for-head-and-neck-cancer\" class=\"medical medical_review\">Overview of treatment for head and neck cancer</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=paraneoplastic-pemphigus\" class=\"medical medical_review\">Paraneoplastic pemphigus</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pathogenesis-clinical-features-and-diagnosis-of-erythema-multiforme\" class=\"medical medical_review\">Pathogenesis, clinical features, and diagnosis of erythema multiforme</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pathogenesis-clinical-manifestations-and-diagnosis-of-pemphigus\" class=\"medical medical_review\">Pathogenesis, clinical manifestations, and diagnosis of pemphigus</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=leukoplakia-the-basics\" class=\"medical medical_basics\">Patient education: Leukoplakia (The Basics)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=mouth-sores-the-basics\" class=\"medical medical_basics\">Patient education: Mouth sores (The Basics)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=screening-and-early-detection-of-melanoma-in-adults-and-adolescents\" class=\"medical medical_review\">Screening and early detection of melanoma in adults and adolescents</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=stevens-johnson-syndrome-and-toxic-epidermal-necrolysis-management-prognosis-and-long-term-sequelae\" class=\"medical medical_review\">Stevens-Johnson syndrome and toxic epidermal necrolysis: Management, prognosis, and long-term sequelae</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=stevens-johnson-syndrome-and-toxic-epidermal-necrolysis-pathogenesis-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">Stevens-Johnson syndrome and toxic epidermal necrolysis: Pathogenesis, clinical manifestations, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=syphilis-epidemiology-pathophysiology-and-clinical-manifestations-in-hiv-uninfected-patients\" class=\"medical medical_review\">Syphilis: Epidemiology, pathophysiology, and clinical manifestations in HIV-uninfected patients</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=the-genodermatoses\" class=\"medical medical_review\">The genodermatoses</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-of-behcet-syndrome\" class=\"medical medical_review\">Treatment of Beh&ccedil;et syndrome</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-of-dry-mouth-and-other-non-ocular-sicca-symptoms-in-sjogrens-syndrome\" class=\"medical medical_review\">Treatment of dry mouth and other non-ocular sicca symptoms in Sj&ouml;gren's syndrome</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-of-erythema-multiforme\" class=\"medical medical_review\">Treatment of erythema multiforme</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-of-herpes-simplex-virus-type-1-infection-in-immunocompetent-patients\" class=\"medical medical_review\">Treatment of herpes simplex virus type 1 infection in immunocompetent patients</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-of-oropharyngeal-and-esophageal-candidiasis\" class=\"medical medical_review\">Treatment of oropharyngeal and esophageal candidiasis</a></li></ul></div></div>","javascript":null}